[
    {
        "pmid": "40544728",
        "title": "Targeting MAP kinase for inhibiting Leishmania promastigotes and amastigotes stages by L-alanine derived molecules and their anticancer potential against PANC-1 cancer cell lines.",
        "abstract": "Home quarter global population World Health Organizations SouthEast Asia Region bear substantial burden Neglected Tropical Diseases NTDs Identifying mean eliminate NTDs region flagship priority since 2014 India Nepal Bangladesh committed eliminating Kalaazar Visceral Leishmaniasis VL sooner end 2026 WHO 2023a context vanillinderived molecule well established inhibiting several kinase present cancer cell high LDsub50sub value along broad therapeutic window view demand suitable oral candidate controlling Leishmania parasitic proliferation human body here reporting ortho vanillin lAlanine amino acid derived ligand molecule t2E2hydroxy3methoxyphenyl methylidene amino propanoate L CuII conjugate Lsub1sub  Lsub3sub watersoluble nontoxic drug candidate treatment Visceral Leishmaniasis silico binding study potential chemotherapeutic target MAP kinase MitogenActivated Protein Kinase PDB id 4QNY undertaken significant binding shown molecules compound demonstrated significant inhibition amastigote proliferation L donovani Lsub1sub exhibited ICsub50sub 1544 μgmlsup1sup Lsub3sub ICsub50sub 1691 μgmlsup1sup L mexicana ICsub50sub value 1750 μgmlsup1sup Lsub1sub 1748 μgmlsup1sup Lsub3sub result comparable standard reference drug Amphotericin B exhibited ICsub50sub 1450 μgmlsup1sup L donovani 1532 μgmlsup1sup L mexicana toxicity study undertaken macrophage THP1 cell line ICsub50sub value quite higher comparison AmphotericinB Additionally potential molecule checked PANC1 cancer cell line comparison normal HPNE cell lines complex caused doublestrand DNA nicks consistent higher cytotoxic activity observed Cancer cell lines Furthermore cell cycle result also confirmed Lsub1sub arrested PANC1 cell G1S phase cell cycle followed increase subG1 phase Lsub1sub shown population latesecondary cellular apoptotic cell increased 235  9356  whereas population earlyprimary apoptotic cell increased 013  control 1208  finding suggest Lsub1sub cause apoptosis cell death programmed",
        "mesh_terms": [
            "Humans",
            "Antineoplastic Agents",
            "Cell Line, Tumor",
            "Protein Kinase Inhibitors",
            "Alanine",
            "Structure-Activity Relationship",
            "Drug Screening Assays, Antitumor",
            "Cell Proliferation",
            "Antiprotozoal Agents",
            "Mitogen-Activated Protein Kinases",
            "Dose-Response Relationship, Drug",
            "Molecular Structure",
            "Leishmania",
            "Molecular Docking Simulation",
            "Parasitic Sensitivity Tests",
            "Benzaldehydes",
            "Leishmania donovani"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40544728/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40435187",
        "title": "Impact of Vgsc-1014 mutations on the feeding pattern of Phlebotomus argentipes.",
        "abstract": "Knockdown resistance allele kdr alleles within para voltagegated sodium channel gene Vgsc common mechanism DDT pyrethroid resistance insect vectors primary Asian visceral leishmaniasis vector Phlebotomus argentipes two kdr allele codon 1014 Vgsc associated insecticide resistance potentially presenting challenge vector control effort Indian subcontinent Here screened Vgsc1014 allele blood meal origin P argentipes female collected September 2013 August 2015 Bangladesh Mymensingh understand Vgsc1014 allele could impact feeding patterns sand fly collection took place parallel vector control agencys biannual indoor residual spraying IRS programme region wildtype leucine wtleucine common allele 667 followed mutant serine 194 phenylalanine allele 139 55 sand fly blood meal 13 came humans bovine origin 61 However sand fly fed human showed strongly contrasting Vgsc1014 genotypic frequency compared feeding blood sources Whilst 81 P argentipes human blood possessed kdr genotype two mutant alleles 81 sand fly feeding blood source possessed genotype wtleucine allele P  0001 Significant spatial variation kdr frequency detected clear temporal trend effect sampling year results significant impact recent IRS analyses association human feeding kdr allele parallel pyrethroid spraying indicates new mechanism kdr allele might impact VL control programs",
        "mesh_terms": [
            "Animals",
            "Phlebotomus",
            "Mutation",
            "Female",
            "Feeding Behavior",
            "Insecticide Resistance",
            "Voltage-Gated Sodium Channels",
            "Alleles",
            "Humans",
            "Insect Vectors",
            "Cattle",
            "Bangladesh",
            "Insect Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40435187/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40168975",
        "title": "The Lifecycle of Phlebotomus argentipes (Diptera: Psychodidae) Sand Fly in a Newly Developed Colony in Bangladesh.",
        "abstract": "Laboratoryestablished sand fly colony provide important material leishmaniasis research however establishment maintenance colony complicated study colony Phlebotomus argentipes P argentipes established using wildcaught sand fly Bangladesh following standard procedure described published literature colony initiated controlled laboratory environment total 430 female P argentipes sand fly collected develop colony multiple generation F0 F6 1034 P argentipes sand fly laid eggs number egg successfully emerged differed significantly wildcaught generation generations except F1 F6 generations significant difference observed incubation period wildcaught F0 laboratoryreared sand fly F1 F6 mean mortality rate highest first instar 139 lowest pupa stage 19 development pupa adult sand fly 98 successful observed copulation much frequent female taken blood meal first successful attempt colonize sand fly Bangladesh laboratory settings studys finding contribute better understanding role P argentipes vector Leishmania parasite Bangladesh well region colony also used xenodiagnoses insecticide resistance monitoring experimental infection generate necessary evidence",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Female",
            "Phlebotomus",
            "Male",
            "Life Cycle Stages",
            "Insect Vectors",
            "Leishmaniasis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40168975/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40005522",
        "title": "Detection of <i>Leishmania donovani</i> DNA from Oral Swab in Visceral Leishmaniasis.",
        "abstract": "Visceral leishmaniasis VL severe form leishmaniasis fatal left untreated 95 cases Leishmaniasis one neglected tropical disease tend thrive developing region world inadequate access healthcare make difficult people even receive diagnosis study examined usefulness oral swab specimen VL diagnosis detecting iLeishmania donovanii DNA oral swab VL patient iL donovaniiinfected mice Eighty oral swab OS blood buffy coat BC sample collected suspected VL case Bangladesh sample evaluated using iLeishmania kinetoplast minicircle DNAi ikDNAi realtime PCR result showed 625 5080 675 5480 case tested positive BC specimen OS respectively OS positivity statistically comparable BC iL donovanii DNA also detected oral swab infected BALBc mouse conventional PCR targeting ilarge subunit ribosomal RNA genei iLSUrRNAi negative uninfected mice study highlight potential practical method molecular diagnosis VL using oral swab noninvasive simple accurate approach",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Animals",
            "Leishmania donovani",
            "Humans",
            "DNA, Protozoan",
            "Mice",
            "Mice, Inbred BALB C",
            "DNA, Kinetoplast",
            "Real-Time Polymerase Chain Reaction",
            "Female",
            "Bangladesh",
            "Male",
            "Mouth"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40005522/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39700671",
        "title": "Diagnostic techniques for visceral leishmaniasis: An overview of methods used in East Africa.",
        "abstract": "Leishmanias parasitic infection caused protozoan belonging genus Leishmania transmitted sand fly Phlebotomus fly old world Lutzomyia New world disease prevalent tropics subtropics Southern Europe affect 15 million 2 million people annually India Bangladesh Sudan South Sudan Brazil Ethiopia account 90 VL cases Leishmania case Asia declining case East Africa especially Somalia Sudan South Sudan Ethiopia Kenya increasing rise East African case partially attributed ongoing armed conflict especially Somalia Sudan Southern Sudan displaced people increased exposure sand fly bites Migration endemic nonendemic regions misdiagnosis famine malnutrition climate change increase HIV case contributing factors clinical diagnosis Leishmania East Africa combine patients clinical sign either serological parasitological test rK39 strip microscopy major method used Diagnosis condition remains challenging current technique limitations including inability detect parasite tissue need specialized expertise prohibitive cost testing equipment low antibody titers risk misdiagnosis due coinfections disease HIV tuberculosis malaria typhoid Various techniques including serological molecular parasitological methods employed attempt address challenges limited success article therefore review technique used Leishmania diagnosis East Africa discusses available new technique aim overcoming current challenges",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Africa, Eastern",
            "Diagnostic Tests, Routine",
            "Leishmania",
            "Animals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39700671/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39617937",
        "title": "Rapid test for Mycobacterium leprae infection: a practical tool for leprosy.",
        "abstract": "Detection infection Mycobacterium leprae allows timely prophylactic treatment thereby reducing transmission well risk permanent leprosyassociated nerve damage However since worldwideimplemented standard test M leprae infection detection infection asymptomatic individual remains major challenge control program endemic areas previous studies developed fieldtested lateral flow assay LFA quantitatively detecting human IgM M lepraespecific phenolic glycolipid antiPGLI marker active past infection rapid test utilizes luminescent backgroundfree upconverting reporter particle UCP immunochromatography ie UCPLF test platform accurate quantitation antiPGLI IgM without operator bias aim study evaluate final version quantitative UCPbased rapid test ie PGLI QURapid using serum fingerstick blood FSB test comprises lateral flow strip standard plastic biodegradable cassette provided humanized recombinant control monitor test performance calculate accurate antiPGLI IgM levels performance QURtest assessed using serum FSB patient leprosy n  214 tuberculosis n  20 buruli ulcer n  19 leishmaniasis n  14 nontuberculous mycobacterial n  35 infections well healthy Dutch individual n  710 humanized recombinant antiPGLI IgM antibodies Plot receiver operating characteristic curve created sensitivity Sn specificity Sp area curve calculated evaluate test performance Test result classified multibacillary leprosy patient 950 Sn 100 Sp using serum 915 Sn 998 Sp using FSB Qualitative test result could read 2 min flow time accurate quantitation 10 min onwards new antiPGLI IgM control support production batch predetermined seropositivity threshold monitoring PGLI QURtest various settings operational version PGLI QURapid pointofcare applicability meet target product profile criteria Thus QURtest ready public health implementations",
        "mesh_terms": [
            "Humans",
            "Mycobacterium leprae",
            "Leprosy",
            "Male",
            "Female",
            "Immunoglobulin M",
            "Adult",
            "Antibodies, Bacterial",
            "Middle Aged",
            "Sensitivity and Specificity",
            "Antigens, Bacterial",
            "Glycolipids",
            "Young Adult",
            "Aged",
            "Adolescent",
            "Chromatography, Affinity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39617937/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39559700",
        "title": "Atypical cutaneous leishmaniasis: a new challenge to VL elimination in South-East Asia.",
        "abstract": "Visceral leishmaniasis VL caused iL donovanii SouthEast Asian endemic country including India Nepal Bangladesh primary focus ongoing VL elimination program major reduction VL case resulting elimination program last two decades effort focused challenge posed potential reservoir within asymptomatic cases HIVcoinfection VL case Post Kalaazar Dermal Leishmaniasis PKDL case continue sustain parasite transmission cycle known newer endemic zones article brings attention new potential parasite reservoir form atypical cutaneous leishmaniasis ACL case caused novel iL donovanii genetic variants iL donovanii mediated ACL emerging phenomenon recent endemic site justify need implementing molecular surveillance tool identify regionspecific iL donovanii variant dermotropic capability potential revert visceral disease timely detection novel ACL causing iL donovanii genetic lineage SouthEast Asian endemic region necessary halt spread ACL potentially crucial sustainability advance made VL elimination",
        "mesh_terms": [
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Asia, Southeastern",
            "Leishmaniasis, Visceral",
            "Disease Eradication",
            "Genetic Variation",
            "Coinfection",
            "Disease Reservoirs"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39559700/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39179149",
        "title": "Post kala-azar dermal leishmaniasis burden at the village level in selected high visceral leishmaniasis endemic upazilas in Bangladesh.",
        "abstract": "post kalaazar Dermal Leishmaniasis PKDL threatens success Visceral Leishmaniasis VL elimination initiative aimed investigate PKDL burden including active search PKDL leprosynegative skin lesion cases also investigated healthseeking behavior perceived level stigma crosssectional survey among inhabitant VLendemic village five VLendemic upazilas VL expert trained medical officer Upazila Health Complexes UHCs leprosy facility PKDL management Frontline worker conducted housetohouse surveys referring PKDL suspect designated centers Data analysis involved Epi Info version 7 IBM SPSS Statistics 25 Among 472435 screened individuals 4022 past VL 085  Among screened population 82 PKDL suspects 62 PKDL case confirmed overall PKDL burden 13 95  CI 1017 10000 population endemic villages Male predominance macular form PKDL observed Thirtynine PKDL patient perceived stigma different levels 27 62 44  received PKDL treatment Medicines unavailability side effect major reason behind treatment interruption Active screening among 137 leprosynegative PKDL suspect yielded 10 73  PKDL cases existence PKDL case VL endemic area concern interepidemic reservoirs per roadmap PKDL burden must reduced 70  100  respectively 2026 2030 NKEP take current burden 13 per 10000 people VL endemic village baseline Integrating active case detection PKDL leprosy hospital screening center feasible worth deploying nationwide",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Female",
            "Cross-Sectional Studies",
            "Adult",
            "Leishmaniasis, Cutaneous",
            "Adolescent",
            "Child",
            "Bangladesh",
            "Young Adult",
            "Middle Aged",
            "Endemic Diseases",
            "Child, Preschool",
            "Infant",
            "Social Stigma",
            "Patient Acceptance of Health Care",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39179149/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39162927",
        "title": "The Elimination Status of Visceral Leishmaniasis in Southeast Asia Region.",
        "abstract": "Visceral leishmaniasis VL caused intracellular parasite transmitted human sandfly bites prevalent throughout Asia Africa Americas Mediterranean area 147 million people risk contracting illness manifestation heterotrophic illness relies Leishmania implicated hosts immunological response ranging asymptomatic severe leishmaniasis potentially lethal effects reviewed literature published till 31st December 2023 worldwide situation leishmaniasis standard novel detection techniques traditional modern treatment strategy endeavor eliminate VL Moreover epidemiological data collected World Health Organizations publicly available databases GraphPad Prism Version 8 used analyze produce figure based epidemiological data Diagnosis parasite tissue serology commonly employed Diagnosis identifying parasite DNA using molecular technique becoming popular Despite recent finding L donovani resistance pentavalent antimoniate medications continues cornerstone medical management VL Amphotericin B lipid formulations injectable paromomycin oral miltefosine among new therapy option researched number reported VL case reduced remarkably last decade due human intervention made eliminate VL Particularly country South East Asian region experienced momentous progress reducing VL case eliminating disease region Owing robust elimination programs country Bangladesh eliminated VL public health concern India Nepal verge elimination Rapid diagnosis effective inexpensive treatment simple access newly discovered medications appropriate vector control welldesigned vaccine required elimination disease burden impoverished area globe",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Humans",
            "Asia, Southeastern",
            "Antiprotozoal Agents",
            "Disease Eradication",
            "Leishmania donovani",
            "Animals",
            "Amphotericin B"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39162927/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39023122",
        "title": "Ophthalmic adverse effects of miltefosine in the treatment of leishmaniasis: a systematic review.",
        "abstract": "Miltefosine stand sole oral medication approved treatment leishmaniasis appearance severe ophthalmic toxicity induced miltefosine context leishmaniasis treatment matter significant concern main objective study present comprehensive summary ophthalmic adverse effect associated miltefosine used treatment leishmaniasis systematic search performed PubMed ScienceDirect Embase Scopus Google Scholar covering article inception June 2023 without language restrictions identify relevant study documenting ocular toxicity following miltefosine treatment leishmaniasis total eight study involving 31 leishmaniasis patient developed ocular toxicity undergoing miltefosine treatment included analysis study conducted various regions five originating India two Bangladesh one Nepal Patients presented spectrum ophthalmic complications including uveitis keratitis scleritis Moorens ulcer Commonly reported symptom included pain redness excessive tearing partial vision impairment permanent blindness light sensitivity appearance white spot eye average patient received miltefosine treatment duration 47 day experiencing onset ocular problems important note risk ocular toxicity increase prolonged use miltefosine Therefore mitigate potential irreversible damage eyes imperative individual undergoing miltefosine therapy undergo regular eye examinations",
        "mesh_terms": [
            "Humans",
            "Antiprotozoal Agents",
            "Phosphorylcholine",
            "Leishmaniasis",
            "Eye Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39023122/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38995021",
        "title": "Discovery of new antigens for serodiagnosis of visceral leishmaniasis in humans and dogs adds valuable tools to our arsenal.",
        "abstract": "Surveillance sustained control visceral leishmaniasis VL require reliable serodiagnostic tools rK39 gold standard antigen VL diagnosis limited documented poor sensitivity certain endemic regions East Africa longevity antibodies making difficult distinguish active cured infections recent publication imBioi Roberts et al A J Roberts HB Ong S Clare C Brandt et al mBio 15e0085924 2024 httpsdoiorg101128mbio0085924 identified new immunogenic iLeishmaniai candidate dog humans dogs combined antigen LdBPK2907901  LdBPK3627001 D4 D46 distinguished symptomatic asymptomatic infections humans LdBPK3236001 D36 antigen produced shortlived antibody performed well patient cohort Bangladesh Ethiopia Kenya study add promising new candidate serodiagnostic toolbox highlight need antigen discovery study may focused regional performance",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Dogs",
            "Animals",
            "Antigens, Protozoan",
            "Serologic Tests",
            "Humans",
            "Dog Diseases",
            "Antibodies, Protozoan",
            "Sensitivity and Specificity",
            "Ethiopia"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38995021/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38900786",
        "title": "A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh.",
        "abstract": "Southeast Asia treatment recommended patient postkalaazar dermal leishmaniasis PKDL Adherence firstline regimen twelve week miltefosine MF low ocular toxicity observed exposure period assessed safety efficacy two shortercourse treatments liposomal amphotericin B LAmB alone combined MF openlabel phase II randomized parallelarm noncomparative trial conducted patient parasitologically confirmed PKDL 6 ≤60 years Patients assigned 20 mgkg LAmB total dose five injection 15 days alone combined allometric MF 3 weeks primary endpoint definitive cure 12 months defined complete resolution papular nodular lesion 80 repigmentation macular lesions Definitive cure 24 month secondary efficacy endpoint 118126 patient completed trial Definitive cure 12 month observed 29 1863 patient receiving LAmB 30 1963 receiving LAmBMF mITT increasing 58 66 respectively 24 months lesion resolvedimproved 12 24 month patient receiving LAmB 90 83 LAmBMF 85 88 qualitative assessment One death unrelated study drugs reported study drugrelated serious adverse event observed frequent adverse drug reaction MFrelated vomiting nausea LAmBrelated hypokalaemia infusion reactions adverse event mild ocular adverse event occurred regimen suitably safe efficacious alternative longcourse MF PKDL South Asia CTRI201704008421",
        "mesh_terms": [
            "Humans",
            "Amphotericin B",
            "Phosphorylcholine",
            "Bangladesh",
            "Male",
            "Antiprotozoal Agents",
            "Adult",
            "Adolescent",
            "Female",
            "Middle Aged",
            "Young Adult",
            "Child",
            "India",
            "Leishmaniasis, Visceral",
            "Treatment Outcome",
            "Leishmaniasis, Cutaneous",
            "Drug Therapy, Combination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38900786/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38727613",
        "title": "Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia.",
        "abstract": "Postkalaazar dermal leishmaniasis PKDL arises dermal complication following visceral leishmaniasis VL infection Current treatment option PKDL unsatisfactory knowledge gap regarding distribution antileishmanial compound within human skin present study investigated skin distribution miltefosine PKDL patients aim improve understanding pharmacokinetics skin target site PKDL Fiftytwo PKDL patient underwent treatment liposomal amphotericin B 20 mgkg plus miltefosine allometric dosing 21 days Plasma concentration miltefosine measured study day 8 15 22 30 punch skin biopsy taken day 22 physiologically based pharmacokinetic PBPK model developed evaluate distribution miltefosine skin Following allometric weightbased dosing regimen median miltefosine concentration day 22 4373 µgg IQR 21946065 µgg skin 3329 µgmL IQR 2594258 µgmL plasma median individual concentration ratio skin plasma 119 IQR 07919 87 4552 patients skin exposure suggested EC90 PK target 106 mgL associated vitro susceptibility Simulations indicated residence time miltefosine skin would 2fold longer plasma estimated mean residence time 604 versus 266 hours respectively study provides first accurate measurement miltefosine penetration skin demonstrating substantial exposure prolonged retention miltefosine within skin finding support use miltefosine cutaneous manifestation leishmaniasis combination parasitological clinical data result critical future optimization combination therapy miltefosine treatment PKDL",
        "mesh_terms": [
            "Humans",
            "Phosphorylcholine",
            "Antiprotozoal Agents",
            "Male",
            "Adult",
            "Leishmaniasis, Cutaneous",
            "Female",
            "Skin",
            "Leishmaniasis, Visceral",
            "Middle Aged",
            "Young Adult",
            "Amphotericin B",
            "Adolescent",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38727613/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38669211",
        "title": "Successful treatment of recurrent visceral leishmaniasis relapse in an immunocompetent adult female with functional hypopituitarism in Bangladesh.",
        "abstract": "Currently available treatment option mostly effective achieving longterm cure visceral leishmaniasis VL patients However report recurrence illness immunosuppressed immunocompetent patients report first case recurrent VL relapse 19yearold immunocompetent female functional hypopituitarism hypogonadotropic hypogonadism central hypothyroidism Bangladesh treated three time previously optimal dosage duration liposomal amphotericin B LAmB alone combination miltefosine treated patient successfully modified treatment regimen 10 mgkg body weight LAmB two consecutive day along oral miltefosine seven day loading dose secondary prophylaxis patient received 3 mgkg body weight LAmB along oral miltefosine seven day monthly five dos followed hormonal replacement patient remained relapse free 12 month treatment completion absence protective vaccine Leishmania specie standard treatment regimen modified treatment regimen could help management recurrent relapse cases",
        "mesh_terms": [
            "Female",
            "Humans",
            "Young Adult",
            "Amphotericin B",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Hypopituitarism",
            "Leishmaniasis, Visceral",
            "Phosphorylcholine",
            "Recurrence",
            "Treatment Outcome",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38669211/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38639536",
        "title": "A panel of recombinant <i>Leishmania donovani</i> cell surface and secreted proteins identifies LdBPK_323600.1 as a serological marker of symptomatic infection.",
        "abstract": "Visceral leishmaniasis deadly infectious disease one worlds major neglected health problems symptom infection similar endemic diseases accurate diagnosis crucial appropriate treatment Definitive diagnosis using splenic bone marrow aspirate highly invasive so serological assay preferred including direct agglutination test DAT rK39 strip test tests however either difficult perform field DAT lack specificity endemic region rK39 making development new test research priority availability iLeishmaniai spp genome present opportunity identify new diagnostic targets Here use genome data mammalian protein expression system create panel 93 protein consisting extracellular ectodomains iLeishmania donovanii cell surface secreted proteins use panel serum murine experimental infection model natural human canine infection identify new candidate serological diagnosis observed concordance immunoreactive antigen different host specie transmission settings antigen encoded iLdBPK3236001i gene diagnose iLeishmaniai infection high sensitivity specificity patient cohort different endemic region including Bangladesh Ethiopia longitudinal sampling treated patients observed reduction immunoreactivity LdBPK3236001 suggesting could used diagnose treatment success summary identified new antigen could contribute improved serological diagnostic test help control impact deadly tropical infectious disease Visceral leishmaniasis fatal left untreated patient often displaying mild nonspecific symptom early stage infection making accurate diagnosis important Current method diagnosis require highly trained medical staff perform highly invasive biopsy liver bone marrow pose risk patient Less invasive molecular test available suffer regional variation ability accurately diagnose infection identify new diagnostic marker visceral leishmaniasis produced tested panel 93 protein identified genome parasite responsible disease found pattern host antibody reactivity protein broadly consistent across naturally acquired infection human patient dogs well experimental rodent infections identified new protein called LdBPK3236001 could accurately diagnose visceral leishmaniasis infection humans",
        "mesh_terms": [
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Animals",
            "Humans",
            "Mice",
            "Dogs",
            "Antigens, Protozoan",
            "Antibodies, Protozoan",
            "Protozoan Proteins",
            "Serologic Tests",
            "Biomarkers",
            "Female",
            "Recombinant Proteins",
            "Mice, Inbred BALB C",
            "Membrane Proteins",
            "Sensitivity and Specificity",
            "Dog Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38639536/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38630832",
        "title": "Perceived needs of disease vector control programs: A review and synthesis of (sub)national assessments from South Asia and the Middle East.",
        "abstract": "Systems disease vector control effective efficient flexible able tackle contemporary challenge threat control elimination vectorborne diseases priority activity towards strengthening vector control systems advocated country conduct vectorcontrol need assessment review carried perceived need disease vector control program among eleven country subnational state South Asia Middle East country state independent team conducted vector control need assessment engagement stakeholders Important weakness described malaria dengue leishmaniases regarding vector surveillance insecticide susceptibility testing monitoring evaluation operations entomological capacity laboratory infrastructure addition community mobilization intersectoral collaboration showed important gaps Countries state expressed concern insecticide resistance could reduce continued effectiveness interventions demand improved monitoring Moreover attainment disease elimination necessitates enhanced vector surveillance Vector control need assessment provided useful planning tool systematic strengthening vector control systems limitation conducting vector control need assessment time resourceintensive increase feasibility utility national assessments abridged version guidance focus operationally relevant topic assessment Similar review needed region different contextual conditions",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Asia, Southern",
            "Dengue",
            "Disease Vectors",
            "Insecticides",
            "Malaria",
            "Middle East",
            "Needs Assessment",
            "Vector Borne Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38630832/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38626228",
        "title": "Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.",
        "abstract": "Postkalaazar dermal leishmaniasis PKDL dermatosis occur successful treatment visceral leishmaniasis VL public health problem VL endemic areas conducted systematic scoping review assess characteristic published PKDL clinical studies understand scope research explore feasibility value developing PKDL individual patient data IPD platform systematic review published literature conducted identify PKDL clinical study searching following databases PubMed Scopus Ovid Embase Web Science Core Collection Global Index Medicus PASCAL Clinicaltrialsgov Ovid Global Health Cochrane Database CENTRAL International Clinical Trials Registry Platform prospective study human PKDL diagnosis treatment followup measurement January 1973 March 2023 included Extracted data includes variable patient characteristics treatment regimens diagnostic methods geographical locations efficacy endpoints adverse event statistical methodology total 3418 record screened 56 unique study n  2486 patients included review 56 studies 36 643 India 19832022 12 214 Sudan 19922021 6 107 Bangladesh 19912019 2 36 Nepal 20012007 Five 89 study published 19811990 n  193 patients 10 179 19912000 n  230 patients 10 179 20012010 n  198 patients 31 554 2011 onwards n  1865 patients Eight 143 randomised clinical trials 48 857 nonrandomised studies median posttreatment followup duration 365 day range 90540 days 8 RCTs 360 day range 282373 days 48 nonrandomised studies Disease diagnosis based clinical criterion 3 54 studies mixture clinical parasitological method 47 839 unclear 6 107 studies Major drug used treatment miltefosine n  636 patients liposomal amphotericin B LAmB n  508 patients antinomy regimen n  454 patients Ten drug regimen tested 270 patient less 60 patient per regimen review identified study limited sample size three major drug miltefosine LAmB pentavalent antimony number patient combined across study suggest IPD platform would valuable support relevant stakeholders global PKDL community sufficient financing PKDL IPD platform realised allow exploration different aspect treatment safety efficacy potentially guide future healthcare decision clinical practices",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Leishmaniasis, Cutaneous",
            "Antiprotozoal Agents",
            "Observational Studies as Topic",
            "Clinical Trials as Topic",
            "Feasibility Studies",
            "Treatment Outcome",
            "India",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38626228/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38353873",
        "title": "Portable smartphone-based molecular test for rapid detection of Leishmania spp.",
        "abstract": "Leishmaniasis caused parasite genus Leishmania neglected tropical disease endemic 60 countries SouthEast Asia Brazil East Africa mainly occurs kalaazar visceral leishmaniasis VL subsequently post kalaazar dermal leishmaniasis PKDL smaller portion cases stated per roadmap accessibility accurate diagnostic method essential step achieve elimination study aimed test accuracy portable minoo device small batterydriven multiuse fluorimeter operating isothermal technology molecular diagnosis VL PKDL Fluorescence data measured device within 20 min reported back mobile application or app via Bluetooth onward via internet backend allows anonymous analysis storage test data test result immediately returned app displaying user limit detection 112 genome copy 95 CI determined screening tenfold dilution range whole Leishmania donovani genome using isothermal recombinase polymerase amplification RPA Pathogens considered differential diagnosis tested crossreactivity observed diagnostic performance DNA extracted 170 VL PKDL cases comprising peripheral blood sample VL n  96 skin biopsy PKDL n  74 India n  108 Bangladesh n  62 screened Clinical sensitivity specificity 88 91 respectively Minoo device offer convenient cheaper alternative molecular diagnostics easy handling make ideal use lowresource setting identify parasite burden",
        "mesh_terms": [
            "Humans",
            "Smartphone",
            "Molecular Diagnostic Techniques",
            "Sensitivity and Specificity",
            "Leishmaniasis, Visceral",
            "Leishmania",
            "Nucleic Acid Amplification Techniques",
            "Leishmaniasis, Cutaneous",
            "Leishmania donovani"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38353873/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38301672",
        "title": "Bangladesh eliminates visceral leishmaniasis.",
        "abstract": "",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Bangladesh",
            "Humans",
            "Animals",
            "Disease Eradication"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38301672/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38132223",
        "title": "Evaluation of a Point-of-Need Molecular Diagnostic Tool Coupled with Rapid DNA Extraction Methods for Visceral Leishmaniasis.",
        "abstract": "rapid costeffective simple nucleic acid isolation technique coupled pointofneed DNA amplification assay desirable goal programmatic use diagnosis Visceral Leishmaniasis VL Recombinase Polymerase Amplification RPA rapid test detection Leishmania DNA versatile operational advantage qPCR facilitate delivery RPA test pointofneed VL diagnosis compared two rapid DNA extraction methods SwiftDx SX inhouse Boil Spin BS method coupled RPA amplification versus widely used method DNA extraction amplification namely Qiagen Q kit qPCR respectively total 50 confirmed VL patient 50 controls matched age gender recruited Mymensingh Bangladesh region highly endemic VL Blood sample collected participant DNA extracted using Q SX BS methods Following DNA extraction qPCR RPA assay performed detect iL donovanii downstream analysis significant difference sensitivity RPA assay observed DNA extraction methods 9400 95 CI 83459875 90 95 CI 78199667 88 95 CI 75699547 using Q SX BS respectively Similarly using qPCR significant difference sensitivity obtained using Q SX DNA extraction 9400 95 CI 83459875 9200 80779778 respectively encouraging RPA qPCR showed excellent agreement k 09190980 different extraction method used DNA impurity using BS inhibitory effect RPA assay Furthermore significantly higher DNA yield obtained using SX BS versus Q however significantly higher parasite load detected using qPCR DNA extracted using Q versus SX Considering cost execution time feasibility performance RPA assay rapid extraction method Boil Spin technique appear potential implementation resourcelimited endemic settings clinical research warranted prior broader application",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38132223/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38123228",
        "title": "Safety and efficacy of primaquine in patients with <i>Plasmodium vivax</i> malaria from South Asia: a systematic review and individual patient data meta-analysis.",
        "abstract": "optimal dosing primaquine prevent relapsing iPlasmodium vivaxi malaria South Asia remains unclear investigated efficacy safety different primaquine regimen prevent iP vivaxi relapse systematic review identified iP vivaxi efficacy study South Asia published 1 January 2000 23 August 2021 onestage metaanalysis available individual patient data cumulative risk iP vivaxi recurrence day 42 180 assessed primaquine total mgkg dose duration risk recurrence day 180 also determined twostage metaanalysis Patients 25 drop haemoglobin 70 gL absolute drop 50 gL day 1 14 categorised daily mgkg primaquine dose 791 patient 7 study onestage metaanalysis day 180 cumulative risk recurrence 611 95 CI 422 804 201 patients 25 recurrences treatment without primaquine 288 95 CI 82 741 398 patients 4 recurrences following low total 2 5 mgkg 0 96 patients 0 recurrences following high total dose primaquine ≥5 mgkg subsequent twostage metaanalysis nine study 3529 patients pooled proportion iP vivaxi recurrence day 180 121 95 CI 77 172 23 95 CI 03 54 07 95 CI 0 61 respectively patient 25 drop haemoglobin 70 gL Primaquine treatment led marked decrease iP vivaxi recurrence following low 35 mgkg high 7 mgkg total doses reported severe haemolytic events CRD42022313730",
        "mesh_terms": [
            "Humans",
            "Primaquine",
            "Malaria, Vivax",
            "Antimalarials",
            "Plasmodium vivax",
            "Recurrence",
            "Asia, Southern",
            "Hemoglobins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38123228/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38110894",
        "title": "A case report on para-kala-azar dermal leishmaniasis: an unresolved mystery.",
        "abstract": "Postkalaazar dermal leishmaniasis PKDL dermatosis occurs 23 year apparently successful treatment visceral leishmaniasis VL rare cases PKDL occurs concurrently VL characterized fever splenomegaly hepatomegaly lymphadenopathy poor nutritional status known Parakalaazar dermal leishmaniasis ParaKDL Coassociation active VL PKDL patient documented Africa case report found South Asia present case Parakalaazar Dermal Leishmaniasis ParaKDL 50yearold male patient history one primary Visceral Leishmaniasis VL 2 time relapse Visceral Leishmaniasis VL patient presented fever skin lesions hepatosplenomegaly Laboratory test revealed LD body slit skin smear splenic biopsy patient treated two cycle Amphotericin B Miltefosine cycle 12 week obtain full recovery case report serf reminder Parakalaazar dermal leishmaniasis develop consequence prior visceral leishmaniasis episodes even apparently effective therapy Since parakalaazar source infectious spread endemic cannot avoided unless effectively recognized treated",
        "mesh_terms": [
            "Male",
            "Humans",
            "Middle Aged",
            "Leishmaniasis, Visceral",
            "Leishmaniasis, Cutaneous",
            "Antiprotozoal Agents",
            "Amphotericin B",
            "Recurrence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38110894/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37951693",
        "title": "Vaccine value profile for leishmaniasis.",
        "abstract": "Leishmania infection global occurring 98 country World Health Organization WHO region 600 million 1 billion people risk infection Visceral leishmaniasis associated almost 20000 reported death annually child 5 year age greatest risk mortality Amongst WHOrecognised Neglected Tropical Diseases NTDs leishmaniasis one important term mortality morbidity increasing global burden disease growing threat climate change urbanisation drug resistance remains imperative develop leishmaniasis vaccines New tool understand correlate protection assess vaccine efficacy developed ease transition larger scale efficacy trial provide alternate route licensure Early indication suggest diverse portfolio manufacturer exists endemic country appetite develop leishmaniasis vaccines Vaccine Value Profile VVP provides highlevel comprehensive assessment currently available data inform potential public health economic societal value leishmaniasis vaccines leishmaniasis VVP developed working group subject matter expert academia public health groups policy organizations nonprofit organizations contributor extensive expertise various element leishmaniasis VVP collectively described state knowledge identified current gaps VVP developed using existing publicly available information",
        "mesh_terms": [
            "Child",
            "Humans",
            "Child, Preschool",
            "Leishmaniasis Vaccines",
            "Leishmaniasis",
            "Leishmaniasis, Visceral",
            "Public Health",
            "Morbidity",
            "Neglected Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37951693/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37943733",
        "title": "Assessment of the impact of implementation research on the Visceral Leishmaniasis (VL) elimination efforts in Nepal.",
        "abstract": "Nepal Bangladesh India signed Memorandum Understanding MoU 2005 eliminate visceral leishmaniasis VL public health problem Indian subcontinent 2015 2021 number reported VL case country declined 95 compared 2007 dramatic success achieved elimination programme implemented early case detection effective treatment vector control disease surveillance community participation operational research underpinned strategies experience offered opportunity assess contribution implementation research IR VL elimination Nepal Desk review stakeholder workshop conducted analyse relationship key research outputs major strategic decision national VL elimination programme annual number reported new case time 2005 2023 result indicated key decision across strategic elements throughout course elimination programme such appropriate tool diganostics treatment best strategy case finding vector management IR informed IR responded dynamically change resulted interventions addressing new question emerged field Close collaboration researchers programme managers implementers priority setting design conduct review study facilitated uptake evidence policy programmatic activities VL case number Nepal reduced 90 compared 2005 Although direct attribution disease decline research output difficult establish Nepal experience demonstrates IR critical enabler disease elimination lesson potentially inform IR strategy country disease targeted elimination",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Insect Control",
            "Nepal",
            "Public Health",
            "Disease Eradication",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37943733/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37862287",
        "title": "Dried Blood Spots (DBS): A suitable alternative to using whole blood samples for diagnostic testing of visceral leishmaniasis in the post-elimination era.",
        "abstract": "Serum whole blood collection processing transport storage still present significant challenge low resource setting mass surveillance required sustain disease elimination Therefore study explored diagnostic efficacy dried blood spot DBS minimally invasive potentially costeffective alternative sampling technique whole blood sampling procedure subsequent detection Leishmania donovani antibody DNA Archived serum DNA sample whole blood visceral leishmaniasis VL case healthy controls DBS corresponding case controls used molecular serological assay optimized detect L donovani antibody DNA DBS elute result compared obtained whole blood Serological assay both rK28 ELISA rK39 ELISA DBS sample showed sensitivity specificity 100 excellent agreement result whole blood sample kappa value ranged 0981 BlandAltman analysis OD value rK28ELISA DBS elute patients serum showed excellent agreement ICC  09 whereas good agreement ICC  08 observed case rK39ELISA However qPCR RPA DBS sample diminished sensitivity 76 68 respectively poor agreement observed whole blood samples result demonstrate DBS offer excellent diagnostic efficiency serological assay represent viable alternative whole blood sampling procedures",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Antigens, Protozoan",
            "Diagnostic Techniques and Procedures",
            "Sensitivity and Specificity",
            "Antibodies, Protozoan",
            "DNA",
            "Dried Blood Spot Testing"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37862287/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37741011",
        "title": "Assessment of treatment outcomes of visceral leishmaniasis (VL) treated cases and impact of COVID-19 on VL management and control services in Bangladesh.",
        "abstract": "COVID19 largely impacted management Visceral leishmaniasis VL like several Neglected Tropical Diseases impact particularly evident Lower MiddleIncome country already inadequate healthcare resource diverted managing COVID19 pandemic Bangladesh achieved elimination target VL 2016 sustain success early diagnosis treatment effective vector control periodic surveillance paramount However specific control measure VL Bangladesh hampered COVID19 extent unknown study aimed identifying gap challenge followup treated VL patient interviewing treated VL case health service providers followed VL case treated 2019 2020 five VL endemic subdistricts upazilas retrospectively prospectively monitor clinical improvement relapse consequences Moreover interview conducted health service provider assess impact COVID19 VL case detection treatment reporting vector control operations logistic supply chain management added delay VL diagnosis however VL treatment initiation reporting time increased almost twofold due COVID19 Indoor Residual Spraying activity significantly hampered due shortage insecticides 44 enrolled treated VL patients two relapsed 45  two developed Para KalaAzar Dermal Leishmaniasis 45  three 68  Post KalaAzar Dermal Leishmaniasis PKDL health service provider highlighted patients unwillingness visit hospital financial constraints distance hospital main reason missed followup visit 205  Building good communication community awareness schemes incentivebased approach suggested possible solution mitigate problems Longterm followup required early detection management VL relapse PKDL cases Effective vector control measures capacity development identification new VL hotspot pivotal VL endemic region sustain elimination goal",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Bangladesh",
            "Pandemics",
            "Retrospective Studies",
            "COVID-19",
            "Treatment Outcome",
            "Recurrence",
            "Leishmaniasis, Cutaneous",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37741011/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37722667",
        "title": "Long-Term Efficacy of Insecticidal Wall Painting for Controlling Visceral Leishmaniasis Vectors in Bangladesh.",
        "abstract": "success visceral leishmaniasis VL elimination program largely depends costeffective vector control measures goal investigate longevity efficacy insecticidal wall painting IWP new vector control tool compared routine indoor residual spraying IRS program reducing VL vector density Bangladesh study extension recent IWP study VL vector management Bangladesh undertaken seven highly VL endemic village Mymensingh district 12month followup 24months followup study collected sand fly additionally 15 18 21 24 month since intervention IWP control where program routine IRS cluster examine longevity efficacy IWP sand fly density reduction mortality differenceindifferences regression model used estimate effect IWP sand fly reduction Program IRS IWP showed excellent performance reducing sand fly density increasing sand fly mortality compared Program IRS effect IWP controlling sand fly statistically significant least 24 months mean female Phlebotomus argentipes density reduction ranged 56 83 P argentipes sand fly mortality ranged 81 995 24month followup period Considering duration efficacy IWP controlling VL vectors Bangladesh National Kalaazar Elimination Program may consider IWP best alternative IRS subsequent phase program",
        "mesh_terms": [
            "Animals",
            "Female",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Insect Control",
            "Bangladesh",
            "Follow-Up Studies",
            "Insect Vectors",
            "Phlebotomus",
            "Psychodidae",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37722667/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37716668",
        "title": "Epidemiological, serological, and entomological aspects of visceral leishmaniasis (VL) in suspected new VL foci in Bangladesh.",
        "abstract": "study aimed explore epidemiological serological entomological aspect visceral leishmaniasis VL suspected new VL focus assess knowledge attitude practice community living alleged new VL foci study investigated new visceral leishmaniasis VL case reported 2019 2020 four subdistricts Dharmapasha Hakimpur Islampur Savar tested 560 member using rK39 rapid test conducted vector collection six neighbouring house index case assess sandfly density distribution examined sandflies infection determined spatial relationship VL infection Furthermore highlighted importance early detection community awareness controlling spread disease study screened 1078 people 231 household four subdistricts fever history visceral leishmaniasis VL PKDLlike skin lesions Among subdistricts positivity rate rK39 rapid test highest 35  Savar Sandflies present across area except Dharmapasha 21 collected female P argentipes sandfly negative Leishmania parasite DNA found one person Islampur history VL one Islampur another one Savar PKDL awareness intervention people became familiar VL infection 912  knowledge concerning sandfly vector disease risk VL increased significantly 301  study found active case suspected new foci asymptomatic individual present sandfly vector exist areas National Kalaazar Elimination Programme NKEP consider area kalaazar endemic initiate control activity per national guidelines",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Female",
            "Leishmaniasis, Visceral",
            "Bangladesh",
            "Phlebotomus",
            "Psychodidae",
            "Fever",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37716668/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "36962767",
        "title": "Real Time PCR-based diagnosis of human visceral leishmaniasis using urine samples.",
        "abstract": "Diagnosis visceral leishmaniasis VL detection causative agent namely Leishmania donovani L infantum traditionally based immunochromatographic tests microscopy bone marrow spleen aspirates liver lymph node differential diagnosis first process low specificity later one carry risk fatal hemorrhage last decade multiple Polymerase Chain Reaction PCR based diagnosis developed using blood urine sample varying degree sensitivity specificity issue worth improving precision diagnosis Earlier reported PCRbased diagnosis L donovani peripheral blood using novel set PCR primer absolute specificity Using set primer PCR conditions describe diagnosis L donovani urine noninvasive rapid safe diagnosis Diagnosis VL carried using urine sample collected clinically diagnosed VL patient n  23 Bangladesh Real Time PCR Test result validated comparing blood sample set patients Sensitivity specificity diagnosis analyzed using retrospective bone marrow samples collected earlier confirmed VL patient n  19 method showed 100 sensitivity detecting L donovani urine corresponding blood retrospective bone marrow samples well 100 specificity control groups Real Time PCRbased molecular detection system using urine sample hereafter presented could a noninvasive approach VL detection precision perfection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36962767/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "36948728",
        "title": "Food- and vector-borne parasitic zoonoses: Global burden and impacts.",
        "abstract": "Around 25 global population suffer one parasitic infections food vectorborne parasitic zoonotic disease major concern Additionally zoonosis communicable diseases common man animals drawing increased attention worldwide Significant change climatic conditions cropping pattern demography food habits increasing international travel marketing trade deforestation urbanization play vital role emergence reemergence parasitic zoonoses Although likely underestimated collective burden food vectorborne parasitic disease account ∼60 million disabilityadjusted life year DALYs 20 neglected tropical disease NTDs listed World Health Organization WHO Centres Disease Control Prevention CDC 13 disease parasitic origin 200 zoonotic disease listed eight neglected zoonotic disease NZDs year 2013 eight NZDs four diseases namely cysticercosis hydatidosis leishmaniasis trypanosomiasis caused parasites review discus global burden impact food vectorborne zoonotic parasitic diseases",
        "mesh_terms": [
            "Animals",
            "Parasites",
            "Zoonoses",
            "Parasitic Diseases",
            "Cysticercosis",
            "Echinococcosis",
            "Neglected Diseases",
            "Global Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36948728/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "36878211",
        "title": "Assessment of Knowledge, Attitudes, and Practices toward Kala-azar in an Endemic District in Bangladesh: A Cross-Sectional Survey.",
        "abstract": "undertook study assess current knowledge attitudes practice related kalaazar advise national kalaazar elimination program Bangladesh communitybased crosssectional study conducted two endemic subdistricts upazilas Fulbaria Trishal Based upazila health complex surveillance data one endemic village selected randomly subdistricts total 511 household HHs 261 Fulbaria 250 Trishal included study adult HH interviewed using structured questionnaire Specifically data collected knowledge attitudes practice related kalaazar respondents 5264 illiterate study participant heard approximately kalaazar 3014 HHs neighboring HHs least one kalaazar case respondents 6888 knew kalaazar transmitted sick people 5653 study participant said mosquito transmitted kalaazar even though 9080 aware presence sand flies participants 4655 aware insect vector laid egg water Upazila Health Complex preferable healthcare facility 8814 villagers addition 6203 used bed net preventing sand fly bite 9648 family mosquito nets Based observations national program strengthen current community engagement activity increase knowledge kalaazar endemic communities",
        "mesh_terms": [
            "Animals",
            "Leishmaniasis, Visceral",
            "Cross-Sectional Studies",
            "Bangladesh",
            "Health Knowledge, Attitudes, Practice",
            "Family Characteristics",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36878211/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "36749281",
        "title": "South Asian Transplant Infectious Disease Guidelines for Solid Organ Transplant Candidates, Recipients, and Donors.",
        "abstract": "guideline discus epidemiology screening diagnosis posttransplant prophylaxis monitoring management endemic infection solid organ transplant SOT candidates recipients donor South Asia guideline also provide recommendation SOT recipient traveling region guideline based literature review expert opinion transplant physicians surgeons infectious disease specialists mostly South Asian country India Pakistan Bangladesh Nepal Sri Lanka well transplant expert countries guideline cover relevant endemic bacterial infection tuberculosis leptospirosis melioidosis typhoid scrub typhus viral infection hepatitis A B C D E rabies arbovirus including dengue chikungunya Zika Japanese encephalitis endemic fungal infection mucormycosis histoplasmosis talaromycosis sporotrichosis endemic parasitic infection malaria leishmaniasis toxoplasmosis cryptosporidiosis strongyloidiasis filariasis well travelers diarrhea vaccination SOT candidate recipient including traveler visiting region guideline intended overview topic detailed review published special supplement Indian Journal Transplantation ",
        "mesh_terms": [
            "Humans",
            "Diarrhea",
            "Travel",
            "Organ Transplantation",
            "Communicable Diseases",
            "Tissue Donors",
            "Transplant Recipients",
            "Zika Virus",
            "Zika Virus Infection"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36749281/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "36720335",
        "title": "A review on new natural and synthetic anti-leishmanial chemotherapeutic agents and current perspective of treatment approaches.",
        "abstract": "Leishmaniases considered among neglected yet dangerous parasitic disease worldwide According recent report Weekly Epidemiological Record Sep 2021 200 country territory reported leishmanises case 2020 89 45 CL 79 40 VL endemic Indian subcontinent India Bangladesh Nepal one three ecoepidemiological hotspot VL currently reported 18 total case VL worldwide Eastern Mediterranean region Region Americas together reported 90 new CL cases 80 Afghanistan Algeria Brazil Colombia Iraq Pakistan Syrian Arab Republic considering current therapeutic options conventional antileishmanial drug long proved toxic andor expensive resulted extensive drug resistance India Recent search novel antileishmanial drug led find prime cellular target metabolic pathway bridge gap known fact unexplored data Cutting edge knowledge based drug designing simplified search novel molecule leishmanicidal efficacy identifying ligandreceptor interaction accelerated cost effective primary discovery molecule computational validation Leishmaniases review focus limitation conventional drugs discusses chemotherapeutic potential many novel natural synthetic antileishmanial agent reported since last decade also interpreted reported molecule might tested singly part combinatorial therapy preclinical clinical level",
        "mesh_terms": [
            "Humans",
            "Leishmania",
            "Leishmaniasis",
            "India",
            "Bangladesh",
            "Nepal",
            "Antiprotozoal Agents",
            "Leishmaniasis, Visceral"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36720335/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "36662825",
        "title": "Revisiting the diagnosis and treatment of Para Kala-azar Dermal Leishmaniasis in the endemic foci of Bangladesh.",
        "abstract": "Para Kalaazar Dermal Leishmaniasis ParaKDL manifest concomitant presence Post Kalaazar Dermal Leishmaniasis Visceral Leishmaniasis work reservoir infection study discusses case management aim address gap within existing method diagnosis treatment retrospective crosssectional study discusses 16 ParaKDL case oneyear followup data treated 20122021 Surya Kanta Kalaazar Research Center Bangladesh collected data hospital record used STATA 16 analyze see frequency distribution variable means found five patient without history kalaazar infection patient treated 20 mgkg Liposomal Amphotericin B 4 divided dos except one history AmBisome hypersensitivity One year treatment patient free skin lesions hepatosplenomegaly observed significant improvement BMI hemoglobin levels ParaKDL patient challenging diagnose relapse treatment failure leishmania patient might belonged rare group contributing poor prognosis Therefore developing appropriate diagnostic workflow new drug regimen essential sustain success elimination efforts",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Antiprotozoal Agents",
            "Retrospective Studies",
            "Bangladesh",
            "Cross-Sectional Studies",
            "Leishmaniasis, Cutaneous"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36662825/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "36493571",
        "title": "Assessment of pan-Leishmania detection by recombinase polymerase amplification assay.",
        "abstract": "spread vector habitat along increasing human mobility introduce atypical Leishmania specie hence challenge existing diagnostic practice rapid detection active infection specie outside narrow target range assessed panLeishmania detection ability isothermal recombinase polymerase amplification RPA assay targeting 18S rRNA gene cathepsin Llike cysteine proteinase B Cpb gene kinetoplast minicircle DNA kDNA regions lowest limit detection 18S rRNARPA CpbRPA assay estimated 12 17 standard DNA molecules respectively assay could amplify genomic DNA 7 pathogenic Leishmania species Evaluation 18S rRNARPA previously developed kDNARPA assay 70 realtime PCRpositive leishmaniasis sample varying pathology resulted sensitivity rate 3571 8857 respectively combined sensitivity 9857 Combinatorial application 18S rRNARPA kDNARPA assay recommended diagnostic assessments",
        "mesh_terms": [
            "Humans",
            "DNA, Kinetoplast",
            "Leishmania",
            "Nucleic Acid Amplification Techniques",
            "Recombinases",
            "RNA, Ribosomal, 18S",
            "Sensitivity and Specificity",
            "Leishmaniasis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36493571/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "36302782",
        "title": "Gauging the skin resident Leishmania parasites through a loop mediated isothermal amplification (LAMP) assay in post-kala-azar dermal leishmaniasis.",
        "abstract": "Despite availability highly sensitive polymerase chain reaction PCRbased methods dearth remotely deployable diagnostic tool circumvents early accurate detection individual postkalaazar dermal leishmaniasis PKDL Here evaluate designlocked loopmediated isothermal amplification LAMP assay diagnose PKDL total 76 snipskin sample collected individual probable PKDL clinical presentation positive rK39 rapid diagnostic test RDT assessed microscopy qPCR LAMP equal number age sexmatched healthy control included determine specificity LAMP assay LAMP assay Qiagen DNA extraction QLAMP showed promising sensitivity 7237 95 CI 60918201 identifying PKDL cases LAMP assay sensitivity declined DNA extracted using boilspin method QqPCR showed 6842 56757861 sensitivity comparable LAMP excellent agreement whereas microscopy exhibited weak sensitivity 3947 28445135 microscopy andor qPCR considered gold standard QLAMP exhibited elevated sensitivity 897 95 CI 78839611 detection PKDL case Bayesian latent class modeling substantiated excellent sensitivity assay healthy control found negative Notwithstanding optimum efficiency LAMP assay towards detection PKDL cases optimization boilspin method warranted permit remote use assay",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Leishmaniasis, Visceral",
            "Leishmania donovani",
            "Parasites",
            "Leishmaniasis, Cutaneous",
            "Bayes Theorem",
            "Skin Diseases, Parasitic",
            "Real-Time Polymerase Chain Reaction"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36302782/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "35381827",
        "title": "First detection of voltage-gated sodium channel mutations in <i>Phlebotomus argentipes</i> collected from Bangladesh.",
        "abstract": "Phlebotomus argentipes main vector visceral leishmaniasis Bangladesh controlled using deltamethrin synthetic pyrethroid indoor residual spraying IRS mutation L1014 leucine codon 1014 voltagegated sodium channel VGSC known knockdown resistance kdr gene thought important pyrethroid resistance mechanism study detected mutation codon 1014 codon 1011 1016 1020 kdr site insects kdr relationship deltamethrin resistance P argentipes IRStargeted site Bangladesh also evaluated Sand fly collected Magurjora village Mymensingh district Bangladesh November 2012 cone bioassay test using deltamethrin conducted specimen grouped live dead morphological identification genomic DNA used genotype partial VGSC gene P argentipes kdr pyrethroid resistance relationship evaluated using Fishers exact test Targeted codon genotyped 8 live 63 dead P argentipes live specimen mutant allele L1014F L1014S codon 1014 mutant allele rate 94 live specimen 55 dead specimens mutant allele survival odds higher wildtype L1014L allele L1014F odds lower L1014S mutation codon 1011 1016 1020 L1014 mutation suggested pyrethroid resistance appeared Bangladesh research kdr mutation P argentipes important appropriate IRS",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Insecticide Resistance",
            "Insecticides",
            "Mutation",
            "Phlebotomus",
            "Pyrethrins",
            "Voltage-Gated Sodium Channels"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35381827/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34983616",
        "title": "Identification of asymptomatic Leishmania infections: a scoping review.",
        "abstract": "Asymptomatic Leishmania infection may play important role transmission parasite endemic areas present consensus definition asymptomatic Leishmania infection safe accessible gold standard test identification paper present scoping review summarize definition asymptomatic Leishmania infection found literature well detail approach molecular serological cellular andor parasitological tests used researcher identify asymptomatic population scoping review published gray literature related asymptomatic Leishmania infection conducted retrieved citation screened based predefined eligibility criteria relevant data item extracted eligible articles analysis descriptive presented using tables figures thematic narrative synthesis conducted screening 3008 articles 175 selected full review articles selected 106 met inclusion criteria article published 1991 2021 last 5 years 38 article reported study conducted Brazil 26 Spain 14 India 12 Bangladesh 10 Ethiopia 7 studies 849 conducted immunocompetent population 151 conducted immunosuppressed population HIV immunosuppressive drugs organ transplantation population report 14 different technique 10 strategy employed researcher define asymptomatic Leishmania infection endemic area definition asymptomatic Leishmania infection unified across literature often includes following criteria residence or extended stay Leishmaniaendemic area reported signssymptoms compatible leishmaniasis positive combination serological molecular cellular andor parasitological tests Caution recommended comparing result different study subject asymptomatic infections reported prevalence cannot confidently compared area due wide variety test employed research groups research importance asymptomatic immunosuppressed immunocompetent Leishmaniapositive population leishmaniasis epidemiology required",
        "mesh_terms": [
            "Asymptomatic Infections",
            "Endemic Diseases",
            "Humans",
            "Leishmaniasis",
            "Neglected Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34983616/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34829309",
        "title": "Development of Quantitative Rapid Isothermal Amplification Assay for <i>Leishmania donovani</i>.",
        "abstract": "Quantification pathogen load although challenging paramount importance accurate diagnosis clinical management range infectious disease pointofneed testing PONT scenario resourcelimited settings formulated quantification approach test standardcurve based absolute quantification ability isothermal recombinase polymerase amplification RPA assay test principle 10fold dilution series iLeishmania donovanii LD genomic DNA prepared nucleasefreewater NFW culturespikedblood CSB tested 15 min assay performed modified algorithm formulated derive detection outcome thresholdrecord time Tr second thus obtained plotted initial load parasite genome loglinear regression analysis quantitative RPA QRPA assay evaluated LD quantitative qPCR assay DNA extracted visceral postKalaazar dermal leishmaniasis case specimen stratified different range threshold cycle Ct bestfitted regression model found linear mean rsup2suproot mean square error RMSE value residual point in seconds estimated 09968063 0992746 replicated series NFW CSB respectively series lower limit detection reached less 01 parasite genome equivalent DNA Absolute agreement QRPA LDqPCR found test positivity strong positive correlation observed Tr Ct value r  089 ipi  00001 well absolute parasite load r  087 ipi  00001 quantified respective assays finding first QRPA assay leishmaniasis suggestive potential monitoring LD load clinical specimens development rapid QRPA assay infectious diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34829309/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34789971",
        "title": "Efficacy and safety of single-dose liposomal amphotericin B in patients with visceral leishmaniasis in Bangladesh: a real-life experience.",
        "abstract": "Liposomal amphotericin B LAmB drug choice Bangladesh eliminate burden visceral leishmaniasis also known kalaazar fatal protozoan parasitic disease left untreated aimed assess efficacy safety singledose 10 mgkg LAmB visceral leishmaniasis VL treatment among visiting child adult tertiary care setting prospective study includes 11 child 19 adult confirmed diagnosis kalaazar total 30 cases Intravenous infusion LAmB 10 mgkg body weight given patients Clinical assessment conducted treatment hospital discharge day 30 180 treatment Efficacy estimated term initial cure at day 30 final cure at 180 days information recorded preformed case record form analysis performed SPSS 22 mean age 2713 ± 1804 year 365 male predominance 60 Significant regression spleen size found following treatment LAmB 30 day 180 day follow visit p  005 all Overall rate initial cure 90 n  27 child 909 v 8947 adult final cure 9666 n  29 child 100 v 9473 adult Fourteen adverse event recorded mostly including fever andor shivering 8571 case relapsed referred either due management Severe Adverse Event SAE reallife experience LAmB treatment visceral leishmaniasis safe effective treatment kalaazar patients online version contains supplementary material available 101007s1263902101379w",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34789971/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34773853",
        "title": "Immunomodulatory role of Th17 pathway in experimental visceral leishmaniasis.",
        "abstract": "Visceral leishmaniasis VL Kalaazar vector borne protozoan infection caused Leishmania donovani Indian subcontinent mainly India Nepal Bangladesh major public health problem country mostly affecting socioeconomically poor population Leishmaniasis rank third important disease malaria filariasis still considered one neglected tropical disease world development better therapeutic agent effective vaccine VL need understand host immunological change play vital role course infection Therefore investigated role Th17 pathway Balbc mouse Leishmania donovani infection treatment amphotericin B Mice divided four group ie Control Infected Uninfected treated Infected treated cytokine level estimated spleen Balbc mouse day 1 3 7 14 17 21 28 35 45 60 post infection course treatment mRNA level Th17 pathway active Leishmania donovani infection treatment determined real time polymerase chain reaction RTPCR protein level flow cytometry ELISA Results study revealed active infection associated low level Th17 cytokine IL17 IL22 IL23 elevated level IL6 IL1β TGFβ Amphotericin B treatment restored production proinflammatory cytokine IL17 IL22 level transcription factor RORγt found correlate level IL17 infection also chemotherapy whereas STAT3 level elevated infection vice versa treatment finding study suggest Th17 cytokine IL17 IL22 associated protection VL infection development intervention chemotherapeutic agent targeting Th17 pathway could important approach VL treatment",
        "mesh_terms": [
            "Animals",
            "Biomarkers",
            "Cricetinae",
            "Cytokines",
            "Disease Models, Animal",
            "Disease Susceptibility",
            "Gene Expression Regulation",
            "Host-Parasite Interactions",
            "Immunomodulation",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Lymphocyte Activation",
            "Mice",
            "Signal Transduction",
            "Spleen",
            "Th17 Cells"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34773853/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34699956",
        "title": "Vector-borne and zoonotic infections and their relationships with regional and socioeconomic statuses: An ID-IRI survey in 24 countries of Europe, Africa and Asia.",
        "abstract": "crosssectional international study aimed analyze vectorborne zoonotic infection VBZI significant global threats VBZIs data May 2028 2018 collected 24 Participatingcountries classified lowermiddle uppermiddle highincome 382 patient included 175458 hospitalized commonly Croatia Egypt RomaniaP  0001 significant difference distribution VBZIs according geographical regionsP  0001 Amebiasis Ancylostomiasis Blastocystosis Cryptosporidiosis Giardiasis Toxoplasmosis significantly common MiddleEast Bartonellosis Borreliosis Cat Scratch Disease Hantavirus syndrome Rickettsiosis Campylobacteriosis Salmonellosis CentralEastSouthEast Europe Brucellosis Echinococcosis CentralWest Asia Campylobacteriosis Chikungunya Tickborne encephalitis Visceral Leishmaniasis Salmonellosis Toxoplasmosis NorthMediterranean CCHF Cutaneous Leishmaniasis Dengue Malaria Taeniasis Salmonellosis Indian Subcontinent Lassa Fever West Africa significant regional difference viral hemorrhagic feversP  0001 tickborne infectionsP  0001 according economic status VBZIsP  0001 prevalence VBZIs significantly higher lowermiddle income countriesP  0001 similar region Indian Subcontinent MiddleEast Indian Subcontinent NorthMediterranean MiddleEast NorthMediterranean regions Regional socioeconomic heterogeneity still exists VBZIs Control eradication VBZIs require evidencebased surveillance data multidisciplinary efforts",
        "mesh_terms": [
            "Africa",
            "Animals",
            "Asia",
            "Cross-Sectional Studies",
            "Europe",
            "Hemorrhagic Fever Virus, Crimean-Congo",
            "Hemorrhagic Fever, Crimean",
            "Humans",
            "Socioeconomic Factors",
            "Zoonoses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34699956/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34695792",
        "title": "Comparison of Novel Sandfly Control Interventions: A Pilot Study in Bangladesh.",
        "abstract": "pilot comparative study investigated compared effect existing vector control tool sandfly density mortality inform support National Kalaazar Elimination Program NKEP intervention included insecticidal wall painting IWP reducedcoverage insecticidal durable wall lining DWL insecticideimpregnated bednets ITN indoor residual spraying deltamethrin IRS Sakhua union seven village study area highly endemic visceral leishmaniasis union Trishal upazila Bangladesh cluster containing different intervention included approximately 50 households Study method included random selection clusters collection sandfly CDC light trap manual aspirator determine sandfly density sandfly mortality determined cone bioassay test Trained field research assistant interviewed household head using structured questionnaire sociodemographic information well safety acceptability interventions Descriptive analytical statistical method measured interventions effect duration sandfly density reduction mortality measured relative efficacy IWP sandfly control DWL ITN IRS differenceindifference regression model found existing intervention effective safe sandfly control different duration effect acceptability relative efficacy IWP sandfly reduction varied 59 91 75 81 30 104 compared DWL ITN IRS respectively different time point 12month followup study result guide NKEP selection sandfly control tools subsequent consolidation maintenance phases",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Construction Materials",
            "Housing",
            "Insect Control",
            "Insect Vectors",
            "Insecticide-Treated Bednets",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Nitriles",
            "Phlebotomus",
            "Pilot Projects",
            "Psychodidae",
            "Pyrethrins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34695792/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34634528",
        "title": "Development and validation of an HPLC-MS/MS method for the quantification of the anti-leishmanial drug miltefosine in human skin tissue.",
        "abstract": "Miltefosine oral drug approved treatment various clinical presentation neglected parasitic disease leishmaniasis cutaneous leishmaniasis postkalaazar dermal leishmaniasis Leishmania parasite reside multiply dermis skin miltefosine orally administered drug currently studied treatment skinrelated type leishmaniasis urgent need accurate assay determine actual miltefosine level human skin tissue optimize treatment regimen targetsite pharmacokinetic studies describe development validation sensitive method quantify miltefosine 4mm human skin biopsy utilizing highperformance liquid chromatography coupled tandem mass spectrometry skin tissue homogenized overnight enzymatic digestion using collagenase A skin homogenate processed protein precipitation phenylbonded solid phase extraction Final extract injected onto Gemini C18 column using alkaline eluent separation elution Detection performed positive ion electrospray ionization followed quadrupole  linear ion trap mass spectrometer using deuterated miltefosine internal standard method validated linear calibration range 41000 ngmL rsup2sup ≥ 09996 using miltefosine spiked digestion solution calibration quality control samples Validation parameter within internationally accepted criteria including intra interassay accuracy precision within± 15 ≤ 15 within± 20 ≤ 20 lower limit quantitation significant matrix effect human skin tissue matrix recovery miltefosine internal standard comparable Miltefosine human skin tissue homogenate stable homogenization incubation 37 °C± 16 h minimum 10 day storage  20 °C homogenization process assay could successfully detect miltefosine skin biopsy patient postkala azar dermal leishmaniasis treated drug Bangladesh",
        "mesh_terms": [
            "Antiprotozoal Agents",
            "Chromatography, High Pressure Liquid",
            "Humans",
            "Leishmania",
            "Pharmaceutical Preparations",
            "Phosphorylcholine",
            "Reproducibility of Results",
            "Tandem Mass Spectrometry"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34634528/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34503557",
        "title": "Evaluation of molecular assays to detect Leishmania donovani in Phlebotomus argentipes fed on post-kala-azar dermal leishmaniasis patients.",
        "abstract": "Postkalaazar dermal leishmaniasis PKDL caused Leishmania donovani LD skin disorder often appears treatment visceral leishmaniasis VL patients PKDL patient potential reservoir LD parasites initiate new epidemic anthroponotic VL Therefore host infectiousness sand fly vector critical factor transmission accurate estimation facilitate control strategies present conventional microscopy serf reference method detect parasite vector However low sensitivity microscopy limiting factor study realtime quantitative PCR LDqPCR recombinase polymerase amplification LDRPA assay evaluated microscopy detection LD DNA extracted live sand fly five day controlled feeding PKDL cases sensitivity LDqPCR LDRPA assay found 9643 100 respectively microscopy selected fed sand fly n  28 absolute specificity molecular tool apparently unfed sand fly n  30 proportion infectious case among 47 PKDL patient estimated 4681 defined microscopic detection LD least one fed sand fly per case LDRPA assay evaluation microscopy negative sand fly fed 47 PKDL case estimated even greater proportion infectious case 5106 overall estimation infectious case retrospective manner discordance positivity rate observed p  005 LDRPA 5957 assay microscopy 4681 LDRPA slightly better positivity rate LDqPCR 5532 well Considering sensitivity cost detection time field applicability RPA assay considered promising single molecular detection tool investigation pertaining LD infection sand fly andor host infectiousness PKDL also useful confirmation microscopy negative sand fly samples",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Phlebotomus",
            "Real-Time Polymerase Chain Reaction",
            "Retrospective Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34503557/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34449767",
        "title": "Micro-CT visualization of a promastigote secretory gel (PSG) and parasite plug in the digestive tract of the sand fly Lutzomyia longipalpis infected with Leishmania mexicana.",
        "abstract": "Leishmaniasis debilitating disease tropics subtropics southern Europe caused Leishmania parasite transmitted blood feeding phlebotomine sand fly Diptera Psychodidae Using noninvasive microcomputed tomography able visualize impact laboratory model infection Lutzomyia longipalpis Leishmania mexicana response second blood meal first time able show 3D plug promastigote secretory gel PSG parasite distended midgut whole infected sand fly measure volume relation midgut also able measure degree opening stomodeal valve demonstrate extension PSG parasite pharynx Although pilot study could examine flies support hypothesis second noninfected blood meal enhances parasite transmission showed thoracic PSGparasite plug infected fly second blood meal was average twice volume plug infected fly second blood meal",
        "mesh_terms": [
            "Animals",
            "Female",
            "Gastrointestinal Tract",
            "Insect Vectors",
            "Leishmania mexicana",
            "Pilot Projects",
            "Protozoan Proteins",
            "Psychodidae",
            "X-Ray Microtomography"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34449767/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34370731",
        "title": "Impact of IRS: Four-years of entomological surveillance of the Indian Visceral Leishmaniases elimination programme.",
        "abstract": "2005 Bangladesh India Nepal agreed eliminate visceral leishmaniasis VL public health problem approach improved case detection treatment controlling transmission sand fly vector Phlebotomus argentipes indoor residual spraying IRS insecticide Initially India applied DDT stirrup pump IRS however reduce transmission 2015 onwards pyrethroid alphacypermethrin applied compression pumps entomological surveillance initiated 2016 Eight sentinel site established Indian state Bihar Jharkhand West Bengal IRS coverage monitored household survey quality insecticide application measured HPLC presence abundance VL vector monitored CDC light traps insecticide resistance measured diagnostic assay case incidence determined VL case register KAMIS Complete treatment house IRS increased across site 57 2016 70 house 2019 rising 80 partial house IRS coverage included except West Bengal quality insecticide application improved compared previous studies average dos insecticide filter paper ranged 152 time target dose 25mgm2 alphacypermethrin 2019 167 time 2018 Resistance DDT continued increase vector resistant carbamates organophosphate pyrethroids annual seasonal abundance P argentipes declined 2016 2019 overall infection rate 003 associated decline VL incidence block represented sentinel site 116 per 10000 population 2016 051 per 10000 2019 effective case detection management reducing infection reservoir P argentipes human population combined IRS keeping P argentipes abundance infectivity low reduced VL transmission combination effective case management vector control brought India within reach VL elimination targets",
        "mesh_terms": [
            "Animals",
            "Biological Assay",
            "Female",
            "Humans",
            "India",
            "Insect Control",
            "Insect Vectors",
            "Insecticide Resistance",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Phlebotomus",
            "Psychodidae",
            "Pyrethrins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34370731/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34280530",
        "title": "Early diagnosis of kala-azar in Bangladesh: Findings from a population based mixed methods research informing the post-elimination era.",
        "abstract": "Global annual report visceral leishmaniasis kalaazar black fever reduced 200000 case 2012 23804 2015 India Bangladesh Nepal reported 80 global case 2012 39 2015 sought identify major amenable barrier early diagnosis kalaazar peripheral area Mymensingh district area Bangladesh highly endemic kalaazar conducted sequential exploratory mixed method research Qualitative data first derived indepth interview focus group discussion among 29 patient diagnosed kalaazar families neighbours Preliminary result qualitative analysis used design structured questionnaire administered collect data process leading diagnosis kalaazar 102 patients Qualitative quantitative data integrated consistent chronology kalaazar patient seeking care study conducted September 2011 May 2012 Fulbaria Gaffargaon subdistricts Mymensingh median delay fever onset confirmatory diagnosis kalaazar 60 days 38 case diagnosed within 30 days Public health facility Gaffargaon subdistrict achieved high proportion early diagnosis Individual barrier early diagnosis low awareness symptom treatment facilities poverty traditional beliefs factor remoteness health care centres wet season transport difficulty misdiagnosis typhoid limited availability rK39 testing community level inclusion splenomegaly case definition Targeted community awareness campaign appropriate underprivileged community increase care seeking consequently diagnosis Improved diagnostic guideline strong referral chain kalaazar accelerate diagnosis step contribute significantly National Kalaazar Elimination Program Bangladesh especially postelimination era",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Aged",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Early Diagnosis",
            "Female",
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Patient Acceptance of Health Care",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34280530/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34273394",
        "title": "PpSP32-like protein as a marker of human exposure to Phlebotomus argentipes in Leishmania donovani foci in Bangladesh.",
        "abstract": "Phlebotomus argentipes predominant vector Leishmania donovani protozoan parasite causing visceral leishmaniasis Indian subcontinent host bitten P argentipes sand fly saliva elicits production specific antisalivary protein antibodies Here utilised antibody marker human exposure P argentipes visceral leishmaniasis endemic area Pabna district Bangladesh use whole salivary gland homogenate antigen detect antibody several limitations therefore superseded use specific recombinant salivary proteins identified three major P argentipes salivary antigenic protein recognised serum bitten humans expressed recombinant form rPagSP04 rPagSP05 rPagSP06 tested applicability ELISA immunoblot One them PpSP32like protein rPagSP06 identified promising antigen showing highest resemblance correlation IgG response P argentipes salivary gland homogenate Furthermore validated applicability rPagSP06 large cohort 585 individual obtained high correlation coefficient antirPagSP06 antiP argentipes saliva IgG responses antirPagSP06 antiP argentipes salivary gland homogenate IgG response followed similar rightskewed distribution first report screening human serum antiP argentipes saliva antibody using recombinant salivary protein rPagSP06 proven valid antigen screening human serum exposure P argentipes bite visceral leishmaniasis endemic area",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Bites and Stings",
            "Humans",
            "Insect Proteins",
            "Leishmania donovani",
            "Phlebotomus",
            "Saliva",
            "Salivary Proteins and Peptides"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34273394/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "34011613",
        "title": "Answer to June 2021 Photo Quiz.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34011613/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "33981632",
        "title": "Evaluation of Loopamp™ <i>Leishmania</i> Detection Kit and <i>Leishmania</i> Antigen ELISA for Post-Elimination Detection and Management of Visceral Leishmaniasis in Bangladesh.",
        "abstract": "reduced prevalence visceral leishmaniasis VL Indian subcontinent ISC direct field deployable diagnostic test needed implement effective diagnostic surveillance algorithm postelimination VL control regard investigated diagnostic efficacy loopmediated isothermal amplification LAMP assay Loopamp™ iLeishmaniai Detection Kit Eiken Chemical CO Ltd Japan realtime quantitative PCR assay qPCR iLeishmaniai antigen ELISA CLINTECH UK different sampling technique evaluated prospect incorporate postelimination VL control strategies Eighty clinically rK39 rapid diagnostic test confirmed VL case 80 endemic healthy control enrolled study Peripheral blood dried blood spot DBS collected participant time diagnosis DNA extracted whole blood WB DBS iviai silica column QIAGEN boil  spin BS method tested qPCR Loopamp Urine collected participant time diagnosis directly subjected iLeishmaniai antigen ELISA 41 patient followed urine sample collected day 30 day 180 treatment ELISA performed sensitivity LoopampWBBS LoopampWBQIA 962 95 CI 89·4399·22 95 95 CI 87·6998·62 respectively sensitivity LoopampDBSQIA 85 95 CI 75·26 92·00 sensitivity qPCRWBQIA qPCRDBSQIA 938 95 CI 86·0197·94 725 95 CI 61·3881·90 respectively specificity molecular assay 100 sensitivity specificity iLeishmaniai antigen ELISA 975 95 CI 91·4799·70 9195 95 CI 84·1296·70 respectively iLeishmaniai antigen ELISA depicted clinical cure day 180 followedup cases Efficacy sustainability identify LoopampWBBS iLeishmaniai antigen ELISA promising minimally invasive VL diagnostic tool support VL diagnostic surveillance activity respectively postelimination era",
        "mesh_terms": [
            "Antigens, Protozoan",
            "Bangladesh",
            "Enzyme-Linked Immunosorbent Assay",
            "Humans",
            "Japan",
            "Leishmania",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Molecular Diagnostic Techniques",
            "Nucleic Acid Amplification Techniques",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33981632/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "33911290",
        "title": "Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis.",
        "abstract": "Post kalaazar dermal leishmaniasis PKDL mucocutaneous disease usually seen apparently cured inadequately treated untreated case visceral leishmaniasis endemic many part India Nepal Bangladesh eastern Africa Sudan Ethiopia Kenya disease usually manifest variable combination hypopigmented patches erythematous succulent papuloplaques nodular lesion face upper body sometimes extending extremities genitalia tongue Atypical morphology presentation uncommon especially endemic areas include photosensitivity verrucous hypertrophic xanthomatous ulcerative lesions Recognition spectrum mucocutaneous change help physician early initiation treatment reducing disease transmission community differential diagnosis depends pattern manifestations lepromatous leprosy closest mimicker Since PKDL cause significant morbidity least initially affected patient continue act reservoir disease active case detection required identify case early control disease transmission community",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33911290/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "33911289",
        "title": "Epidemiology of Post-Kala-azar Dermal Leishmaniasis.",
        "abstract": "Postkalaazar dermal leishmaniasis PKDL cutaneous sequel visceral leishmaniasis VL kalaazar become entity epidemiological significance virtue ability maintain disease circulation interepidemic periods PKDL identified one epidemiological marker kalaazar elimination programme Data obtained 2018 showed PKDL distribution primarily concentrated 6 countries includes India Sudan south Sudan Bangladesh Ethiopia Nepal decreasing order caseburden India PKDL case mainly found 54 districts 33 Bihar 11 West Bengal 4 Jharkhand 6 Uttar Pradesh West Bengal district reporting case PKDL case include Darjeeling Uttar Dinajpur Dakshin Dinajpur Malda Murshidabad vulnerability young age documented various studies study also highlight male predominance disease recent active surveillance suggested macular form PKDL show femalepredominance recommended along passive case detection active survey help early identification cases thus reducing disease transmission community iAccelerated plan Kalaazar eliminationi 2017 introduced Government India goal eliminate Kalaazar public health problem target reduceing annual incidence 110000 iLeishmania donovanii established causative agent others like iL tropicai iL infantumi may occasionally lead disease especially HIVcoinfection Dermal tropism parasite attributed overexpression parasite surface receptor like gp 63 gp46 Various host factor also identified contribute development disease including high pretreatment IL 10 parasite level inadequate dose duration treatment malnutrition immunosuppression decreased interferongamma receptor 1 gene etc PKDL mostly concentrated plain altitude 600 mt attributed environment conducive vector sand fly iPhlebotumusi Risk factor also linked habitat sand fly Keeping thing mind Integrated vector control adopted iNational vector borne disease control programmei one strategy bring disease burden",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33911289/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "33809332",
        "title": "A Multi-Country, Single-Blinded, Phase 2 Study to Evaluate a Point-of-Need System for Rapid Detection of Leishmaniasis and Its Implementation in Endemic Settings.",
        "abstract": "advancement isothermal nucleic acid amplification techniques detection pathogenic DNA clinical sample pointofneed longer dream newly developed recombinase polymerase amplification RPA assay incorporated suitcase laboratory shown promising diagnostic efficacy realtime PCR detection ileishmaniai DNA clinical samples broader application pointofneed system undertook current multicountry diagnostic evaluation study towards establishing technique different endemic setting would beneficial ongoing elimination program leishmaniasis study purpose clinical sample confirmed visceral leishmaniasis VL postkalaazar dermal leishmaniasis PKDL patient subjected realtime PCR RPA assay Bangladesh India Nepal skin sample confirmed cutaneous leishmaniasis CL patient also included Sri Lanka total 450 clinical sample VL patients 429 PKDL patients 47 CL patients 322 endemic healthyhealthy control investigation determine diagnostic efficacy RPA assay comparison realtime PCR comparative sensitivity method found realtime PCR RPA assay showed 9686 95 CI 94459842 8885 95 CI 85089196 sensitivity respectively diagnosis VL cases new isothermal method also exhibited promising diagnostic sensitivity 9350 PKDL cases skin sample used Due variation sequence target amplicons RPA assay showed comparatively lower sensitivity 5532 realtime PCR Sri Lanka diagnosis CL cases Except India assay presented absolute specificity rest sites Excellent concordance two molecular method towards detection ileishmaniai DNA clinical sample substantiates application RPA assay incorporated suitcase laboratory pointofneed diagnosis VL PKDL low resource endemic settings However improvisation method necessary diagnosis CL",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33809332/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "33768013",
        "title": "Towards a Sustainable Vector-Control Strategy in the Post Kala-Azar Elimination Era.",
        "abstract": "Visceral leishmaniasis VL potentially deadly parasitic disease Indian subcontinent VL caused iLeishmania donovanii transmitted iviai bite infected iPhlebotomus argentipesi female sand fly competent vector specie region highest disease burden northern part Indian subcontinent especially state Bihar India Bangladesh Nepal embarked initiative coordinated World Health Organization eliminate VL public health problem year 2020 main goal reduce VL incidence one case per 10000 people early casedetection prompt diagnosis treatment reduction transmission using vector control measures Indoor residual spraying major pillar elimination program vector control strategy used government India Though India close VL elimination target important aspect vector bionomics sand fly transmission dynamic yet determined achieve sustained elimination prevent resurgence VL knowledge gap vector biology behavior constraint may pose current vector control methods need addressed Herein discus success failure previous current vectorcontrol strategy implemented combat kalaazar Bihar India identify gap understanding vector transmission towards development innovative tool ensure sustained vector control postelimination period",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Female",
            "India",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Nepal"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33768013/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "33763264",
        "title": "Mixed Cutaneous Infection Caused by Leishmania and Dermatophytes: A Rare Coincidence or Immunological Fact.",
        "abstract": "Leishmaniasis first described 1824 Jessore district Bengal now Bangladesh prevalent Bihar Uttar Pradesh Jharkhand West Bengal disease associated depressed cellular immunity Tinea fungal infection skin become extensively pathogenic particularly patient depressed cellmediated immunity Regulatory cell Th17 cell shown responsible postkalaazar dermal leishmaniasis PKDL present rare case 52yearold house wife history recurrent itching depigmentation skin extremities loss appetite 23 month followed progressive spread lesion body apparently healthy female examination many hypopigmented scaly lesion mainly extensor aspect body Skin lesion characteristic tinea infection without PKDL diagnosis PKDL tinea made based history kalaazar skin slit smear amastigote forms irK39i test KOH mount Routine blood investigation showed negative serology HIV lower normal CD4T counts patient advised treatment systemic antifungal therapy antihistaminics later miltefosine highlighted PKDL although uncommon distinct manifestation VL case study also tried find reason coinfection probably due depressed cellular immunity skin abruptions acquired dermatophytic infection prevalent associated lower CD4 cell count",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33763264/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "33686764",
        "title": "Domestic mammals as reservoirs for Leishmania donovani on the Indian subcontinent: Possibility and consequences on elimination.",
        "abstract": "Leishmania donovani causative agent historically anthroponotic visceral leishmaniasis VL Indian subcontinent ISC L donovani transmitted sand fly specie Phlebotomus argentipes collaborative group others shown sand fly trapped outside endemic village fed cattle dog addition people Domestic animal reservoir L donovani complex spp particularly L infantum endemic areas Multiple study using quantitative PCR serological detection method demonstrated goats cattle rat dog diagnostically positive L donovani infection exposure eastern Africa Bangladesh Nepal India limited understanding extent L donovani infection domestic animal drive transmission animal human ISC Evidence vectorborne disease elimination strategy indicated emerging infection domestic specie hindered eradication predominant lesson learned situation nonhuman reservoir must identified controlled andor prevented Massive effort underway VL elimination Indian subcontinent Despite herculean efforts residual VL incidence persists spectre animal reservoir complicating elimination effort haunt final push towards full VL control Better understanding L donovani transmission Indian subcontinent rigorous consideration nonhuman reservoir alter VL ecology critical sustain elimination goals",
        "mesh_terms": [
            "Animals",
            "Cattle",
            "Cattle Diseases",
            "Dog Diseases",
            "Dogs",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Mammals",
            "Phlebotomus",
            "Psychodidae",
            "Rats",
            "Rodent Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33686764/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "33597000",
        "title": "Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.",
        "abstract": "Asymptomatic Leishmania infection outnumber clinical infection Indian subcontinent ISC disease reservoir anthroponotic Diagnostics detect active asymptomatic infection suitable monitoring surveillance may benefit visceral leishmaniasis VL elimination campaign ISC Quantitative polymerase chain reaction qPCR loopmediated isothermal amplification LAMP direct agglutination test DAT carried blood samples Leishmania antigen ELISA carried urine sample collected 720 household neighbouring contact 276 VL postkalaazar dermal leishmaniasis PKDL index cases symptom history VL PKDL endemic region Bangladesh September 2016 March 2018 720 contact index cases asymptomatic infection detected 69 96 participant combination qPCR 10 LAMP 21 DAT 39 Leishmania antigen ELISA 33 one 01 participant detected positive four diagnostic tests Poor agreement test calculated using Cohens kappa κ statistics however Leishmania antigen ELISA DAT combination captured participant positive one test find evidence moderately strong association index case PKDL case OR 194 p  0009 specifically macular PKDL OR 212 p  0004 positive least one four tests Leishmania antigen ELISA urine detects active asymptomatic infection requires noninvasive sample therefore may benefit monitoring transmission surveillance elimination setting combination serology Development antigen detection test rapid diagnostic test RDT format would benefit elimination campaign",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Aged",
            "Antibodies, Protozoan",
            "Antigens, Protozoan",
            "Asymptomatic Infections",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Enzyme-Linked Immunosorbent Assay",
            "Female",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Molecular Diagnostic Techniques",
            "Nucleic Acid Amplification Techniques",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33597000/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "33572506",
        "title": "Rodent Ectoparasites in the Middle East: A Systematic Review and Meta-Analysis.",
        "abstract": "Rodents carry many ectoparasites ticks lice fleas mites potential public health importance Middle Eastern country hotspot many emerging reemerging infectious diseases plague leishmaniasis Crimean Congo hemorrhagic fever Q fever due ecological socioeconomic political diversity Rodent ectoparasite act vector many pathogens Knowledge rodent ectoparasite prime importance controlling rodent ectoparasiteborne zoonotic disease region current systematic review metaanalysis performs comprehensive synthesis available knowledge providing evidencebased overview ectoparasite detected rodent Middle Eastern countries Following systematic search Pubmed Scopus Web Science total 113 published article rodent ectoparasite studied analyzed total 87 rodent specie documented iMus musculusi iRattus norvegicusi iRattus rattusi found common Fleas reported ectoparasite 87 articles followed mite 53 tick 44 louse 25 iXenopsylla cheopisi iPolyplax spinulosai iOrnithonyssus bacotii iHyalomma rhipicephaloidesi commonly described fleas lice mites ticks respectively Based reviewed articles median flea louse mite tick index highest Israel 415 Egypt 139 Egypt 127 Saudi Arabia 117 respectively Quantitative metaanalysis using randomeffects model determined overall pooled flea prevalence Middle East 40 95 CI 2555 iIisup2sup  100 ipi  000001 ranging 13 95 CI 030 iIisup2sup  95 ipi  000001 Iran 59 95 CI 4277 iIisup2sup  75 ipi  000001 Israel overall pooled louse prevalence found 30 95 CI 1347 iIisup2sup  100 ipi  000001 ranging 25 Iran 95 CI 150 iIisup2sup  99 38 Egypt 95 CI 768 iIisup2sup  100 case mites pooled prevalence region 33 95 CI 1155 iIisup2sup  100 ipi  000001 countryspecific prevalence estimate 30 Iran 95 CI 456 iIisup2sup  99 32 Egypt 95 CI 076 iIisup2sup  100 ticks overall prevalence found 25 95 CI 247 iIisup2sup  100 ipi  000001 ranging 16 Iran 95 CI 725 iIisup2sup  74 42 Egypt 95 CI 185 iIisup2sup  100 control rodent ectoparasite considered reduce adverse effects Using One Health strategy rodent control precisely control common rodent species ie iMus musculusi iRattus norvegicusi iRattus rattusi considered control rodentborne ectoparasite region",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33572506/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "33251349",
        "title": "Leishmaniasis in Dhaka Medical College-experience of three years.",
        "abstract": "Peoples Republic Bangladesh working eliminate visceral leishmaniasis Kalaazar case since memorandum understanding signed neighboring country 2005 part elimination activity 44 case Kalaazar diagnosed treated regional referral center Dhaka Medical College Hospital DMCH last three years reported here Confirmed leishmaniasis case included Patients attending specialized center different demographic characteristic varied presentation laboratory finding reviewed recorded structured case record form Ethical clearance obtained prior starting study total 44 patient leishmaniasis reviewed Approximately 89 n  39 New Kalaazar NKA 7 n  3 Relapse Kalaazar Relapse KA one case 2 Kalaazar Treatment Failure KATF Post Kalaazar Dermal Leishmaniasis PKDL both mean age presentation 32 years Forty percent patient house made mud 26 tin shed rest lived building semibuildings predominant clinical feature fever 909 pallor 886 splenomegaly 818 hepatomegaly 682 rK39 positive 907 cases 944 case positive LD body splenic aspirate all 9090 treated Inj Liposomal amphotericin B 910 combination Inj Liposomal Amphotericin B Inj Miltefosine Moving forward elimination leishmaniasis Bangladesh study highlight status characteristic treatment disease country",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33251349/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "33147502",
        "title": "Evidence-based diagnostic algorithm for visceral leishmaniasis in Bangladesh.",
        "abstract": "Evidencebased diagnostic algorithm highly recommended visceral leishmaniasis VL crosssectional study performed Bangladesh evaluate VL diagnostic tool including serology buffy coat smear microscopy LD body various DNAbased technique using buffy coat 100 confirmed VL case 100 controls performance tool spleen smear gold standard evaluated using kappa coefficient Diagnostic precision inherent indicator considered index scoring IS performance tool using factor analysis diagnostic algorithm formulated based availability tool different health care facility Bangladesh high level agreement kappa ≥ 080 observed diagnostic tools highest kappa coefficient found rK39 RDT rK39 ELISA 095 followed ssuRNAPCR 094 Buffy coat smear 093 rK28 ELISA 092 rK28 RDT 089 LAMP 089 Miniexon PCR 086 ITS1 085 ITS2 PCR 080 rK39 RDT found best diagnostic test IS 17 followed rK28 RDT IS 15 buffy coat smear microscopy IS 05 rK39  rK28 ELISA IS 03 ssuRNAPCR IS 07 LAMP Miniexon ITS1  ITS2 PCR IS 09 rK39 RDT proposed best option primary health care facilities buffy coat smear microscopy found good adjunct confirmation serologypositive case proposed secondary tertiary facilities ssuRNAPCR LAMP alternate confirmation tool applicable tertiary facilities",
        "mesh_terms": [
            "Algorithms",
            "Bangladesh",
            "Case-Control Studies",
            "Cross-Sectional Studies",
            "Diagnostic Tests, Routine",
            "Enzyme-Linked Immunosorbent Assay",
            "Evidence-Based Practice",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Microscopy",
            "Polymerase Chain Reaction",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33147502/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "33116091",
        "title": "Clinical and Hematological Features of Visceral Leishmaniasis at Mymensingh Medical College Hospital.",
        "abstract": "Visceral Leishmaniasis severe form leishmaniasis fatal absence treatment Mortality high untreated case 90 Clinical case series document 5 case fatality rate kalaazar patient hospital complication disease Nepal India Bangladesh Brazil Sudan constitute five country world 90 visceral leishmaniasis occurs Mymensingh accounted 50 total kalaazar case reported Bangladesh observational study done SKKRC Mymensingh Medical College Hospital Mymensingh Bangladesh 1st august 2013 28th February 2014 find various clinical feature hematological picture visceral leishmaniasis Total 100 diagnosed case visceral leishmaniasis taken Among total patient male female nearly equally affected kalaazar age group affected kalaazar 2 year 50 years Poor people society affected kalaazar Mymensingh highest incidence kalaazar among different district Bangladesh Pyrexia pallor weight loss main symptom visceral leishmaniasis Abdominal distension jaundice vomiting cough bleeding manifestation less frequent symptom kalaazar Hepatosplenomegaly frequent sign kalaazar Majority patient anemia leucopenia thrombocytopenia ESR frequently raised kalaazar patient among patient many high ESR 100 mm 1st hour conclusion prolong fever progressive pallor anorexia weight loss hepatosplenomegaly endemic area main clinical feature visceral leishmaniasis Anemia leucopenia thrombocytopenia bicytopenia pancytopenia high ESR frequently found hematological picture visceral leishmaniasis",
        "mesh_terms": [
            "Bangladesh",
            "Female",
            "Humans",
            "India",
            "Leishmaniasis, Visceral",
            "Male",
            "Nepal",
            "Splenomegaly"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33116091/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "32973088",
        "title": "Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.",
        "abstract": "Understanding spatiotemporal transmission infectious disease improved significantly recent years Advances Bayesian inference method individuallevel geolocated epidemiological data enabled reconstruction transmission tree quantification disease spread space time accounting uncertainty missing data However method rarely applied endemic disease one asymptomatic infection play role additional estimation method required Here develop method analyze longitudinal incidence data visceral leishmaniasis VL sequela postkalaazar dermal leishmaniasis PKDL highly endemic community Bangladesh Incorporating recent data VL PKDL infectiousness show VL case drive transmission incidence high contribution PKDL increase significantly VL incidence decline reaching 55 setting Transmission highly focal 85 mean distance inferred infectors secondary VL case 300 m estimated average time infector onset secondary case infection 4 mo 88 VL infectors 29 PKDL infectors Estimated number secondary case per VL PKDL case varied 0 6 strongly correlated infectors duration symptoms Counterfactual simulation suggest prevention PKDL could reduced overall VL incidence 25 result highlight need prompt detection treatment PKDL achieve VL elimination Indian subcontinent provide quantitative estimate guide spatiotemporally targeted intervention VL",
        "mesh_terms": [
            "Asymptomatic Infections",
            "Bangladesh",
            "Coinfection",
            "Contact Tracing",
            "Endemic Diseases",
            "Humans",
            "Incidence",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Longitudinal Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32973088/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "32803128",
        "title": "Insights from mathematical modelling and quantitative analysis on the proposed WHO 2030 targets for visceral leishmaniasis on the Indian subcontinent.",
        "abstract": "Visceral leishmaniasis VL neglected tropical disease NTD caused iLeishmaniai protozoa transmitted female sand flies Indian subcontinent ISC VL targeted World Health Organization WHO elimination public health problem 2020 defined 1 VL case new relapse per 10000 population district level Nepal subdistrict level Bangladesh India currently process formulating 2030 targets asking whether maintain 2020 target modify it adding target zero mortality among detected cases NTD Modelling Consortium developed various mathematical VL transmission model gain insight transmission dynamic VL identify main knowledge gaps predict feasibility achieving sustaining target simulating impact varying intervention strategies According models current target feasible appropriate districtsubdistrict level setting medium VL endemicities up 5 reported VL case per 10000 population per year prior start interventions However setting higher precontrol endemicities additional effort may required also highlight risk postkalaazar dermal leishmaniasis PKDL may pose reaching sustaining VL targets therefore advocate adding control PKDL case new 2030 targets Spatial analysis revealed local hotspot high VL incidence remain warn current target provides perverse incentive detectreport case target approached posing risk truly achieving elimination public health problem although taken consideration procedure validation Ongoing modelling work focus risk recrudescence intervention relaxed elimination target achieved",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32803128/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "32517156",
        "title": "Evaluation of Rapid Extraction Methods Coupled with a Recombinase Polymerase Amplification Assay for Point-of-Need Diagnosis of Post-Kala-Azar Dermal Leishmaniasis.",
        "abstract": "detect Postkalaazar leishmaniasis PKDL cases several molecular method promising diagnostic efficacy developed involve complicated expensive DNA extraction methods thus limiting application resourcepoor settings alternative evaluated two rapid DNA extraction method determined impact detection parasite DNA using newly developed recombinase polymerase amplification RPA assay Skin sample collected suspected PKDL case following diagnosis national guidelines extracted DNA three skin biopsy sample using three different extraction method subjected RPA qPCR qPCR RPA assay exhibited highest sensitivity reference DNA extraction method using Qiagen Q kit followed contrast sensitivity RPA assay dropped 767 633 respectively boil  spin BS SpeedXtract SE rapid extraction method performed Despite compromised sensitivity BSRPA technique yielded excellent agreement QqPCR k  0828 QRPA k  0831 techniques expected reference DNA extraction method found superior term diagnostic efficacy Finally apply rapid DNA extraction method resourceconstrained settings methodological refinement warranted improve DNA yield purity rigorous experiments",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32517156/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "32491143",
        "title": "Recurrent kala-azar: report of two cured cases after total splenectomy.",
        "abstract": "Latin America causative agent kalaazar intracellular protozoan Leishmania infantum case South America reported Brazil Worldwide mainly affect Bangladesh Ethiopia India South Sudan Sudan Despite high morbidity lethality kalaazar infection asymptomatic However small portion patient evolves recurrence kalaazar becoming symptomatic even available drug treatments Kalaazar formal indication splenectomy adults Splenectomy recommended saving measure kalaazar associated symptomatic hypersplenism drugresistant cases study report two case kalaazar splenomegaly presented several hospitalization due recurrence kalaazar addition hospitalization normalizing blood count splenectomy kalaazar case effect hypersplenism cured Thus splenectomy seen surgical treatment option curative purpose patient recurrent kalaazar possibility drug therapy exhausted even progressed hypersplenism clinical repercussions",
        "mesh_terms": [
            "Adult",
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Recurrence",
            "Splenectomy",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32491143/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "32295617",
        "title": "An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes.",
        "abstract": "Visceral leishmaniasis VL caused dimorphic Leishmania specie parasitic disease high socioeconomic burden endemic area worldwide Sustaining control VL term proper prevailing immunity development global necessity amid unavailability prophylactic vaccine Screening experimental proteome human disease propagating form Leishmania donovani amastigote pragmatic silico mining novel vaccine candidates using immunoinformatic approach CD4 CD8 cellspecific epitope experimentally reported L donovani protein secretory potential increased abundance amastigotes screened chimera linked Tolllike receptor 4 TLR4 peptide adjuvant constructed evaluated physicochemical characteristics binding interaction TLR4 simulated physiological condition trend immune response following hypothetical immunization Selected epitope physiologically important L donovani protein found mostly conserved L infantum covering theoretically 98 global population multiepitope chimeric vaccine predicted stable antigenic nonallergenic Structural analysis vaccineTLR4 receptor docked complex molecular dynamic simulation suggest sufficiently stable binding interface along prospect noncanonical receptor activation Simulation dynamic immune response following hypothetical immunization indicate active memory B well CD4 cell generation potential likely chance Th1 polarized response methodological approach result study could facilitate informed screening selection candidate antigenic protein entry vaccine production pipeline future control human VL",
        "mesh_terms": [
            "Adjuvants, Immunologic",
            "Antigens, Protozoan",
            "CD4-Positive T-Lymphocytes",
            "CD8-Positive T-Lymphocytes",
            "Computational Biology",
            "Epitopes, T-Lymphocyte",
            "Leishmania donovani",
            "Leishmania infantum",
            "Leishmaniasis Vaccines",
            "Leishmaniasis, Visceral",
            "Molecular Docking Simulation",
            "Molecular Dynamics Simulation",
            "Proteomics",
            "Protozoan Proteins",
            "Vaccines, Subunit"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32295617/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "32228668",
        "title": "Report of the Fifth Post-Kala-Azar Dermal Leishmaniasis Consortium Meeting, Colombo, Sri Lanka, 14-16 May 2018.",
        "abstract": "5th PostKalaAzar Dermal Leishmaniasis PKDL Consortium meeting brought together PKDL expert endemic area review discus existing new data PKDL report summarizes presentation discussion provides overall conclusion recommendations",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Kinetics",
            "Leishmaniasis Vaccines",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Sri Lanka",
            "Xenodiagnosis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32228668/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "32209228",
        "title": "Global genome diversity of the <i>Leishmania donovani</i> complex.",
        "abstract": "Protozoan parasite iLeishmania donovanii complex  iL donovanii iL infantumi  cause fatal disease visceral leishmaniasis present first comprehensive genomewide global study 151 cultured field isolates representing geographical distribution iL donovanii isolates separated five group largely coincide geographical origin vary greatly diversity contrast majority iL infantumi sample fell one globallydistributed group little diversity picture complicated several hybrid lineages Identified genetic group vary heterozygosity level linkage suggesting different recombination histories characterise chromosomespecific pattern aneuploidy identified extensive structural variation including known suspected drug resistance loci study reveals greater genetic diversity suggested geographicallyfocused studies provides resource genomic variation future work set scene new understanding evolution genetics iLeishmania donovanii complex",
        "mesh_terms": [
            "Aneuploidy",
            "Animals",
            "DNA Copy Number Variations",
            "Drug Resistance",
            "Evolution, Molecular",
            "Genetic Variation",
            "Genome, Protozoan",
            "Heterozygote",
            "Leishmania donovani",
            "Polymorphism, Single Nucleotide",
            "Selection, Genetic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32209228/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "31995564",
        "title": "Male predominance in reported Visceral Leishmaniasis cases: Nature or nurture? A comparison of population-based with health facility-reported data.",
        "abstract": "Bangladesh India Nepal aim elimination Visceral Leishmaniasis VL systemic parasitic infectious disease public health problem 2020 decades male patient comprised majority reported VL case region comparing reported VL sex ratio one observed populationbased study conducted Indian subcontinent tested working hypothesis mainly sociocultural gender difference healthcareseeking behavior explain gender imbalance compared observed sex ratio male versus female among VL case reported health system Nepal two endemic state India observed populationbased cohort study India Nepal Also assessed male sex potential risk factor seroprevalence baseline seroconversion VL incidence populationbased data malefemale ratio among VL case reported health system 140 95 CI 137143 population cohort data age study siteadjusted male female risk ratio 127 95 CI 108151 Also male 19 higher chance seropositive baseline population survey RR 119 95 CI 111127 observed significant difference seroconversion rate sex DAT cutoff titer defined primary endpoint populationbased data show male sex risk factor VL sociocultural determinant Biological sexrelated difference likely play important role pathogenesis disease",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Child",
            "Child, Preschool",
            "Disease Notification",
            "Health Facilities",
            "Humans",
            "Incidence",
            "Infant",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Seroepidemiologic Studies",
            "Sex Ratio",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31995564/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "31699125",
        "title": "Imported cutaneous leishmaniasis: molecular investigation unveils Leishmania major in Bangladesh.",
        "abstract": "main clinical form leishmaniasis Bangladesh visceral leishmaniasis postkalaazar dermal leishmaniasis caused Leishmania donovani Imported cutaneous leishmaniasis CL emerging globally due mainly increased human mobility recent years several imported CL case also reported Bangladesh Sporadic atypical case CL challenging diagnosis clinical management occurrence infection frequent basis alarming report case Bangladeshi temporarymigrant worker who upon return presented development skin lesion characteristic CL serum sample collected tested rK39 immunochromatographic test Nucleic acid skin biopsy derived culture sample extracted screened realtime PCR assay target conserved REPL repeat region L donovani complex internal transcribed spacer 2 region ribosomal RNA gene cluster amplified sequenced suspect history travel CL VL endemic area positive rK39 test result Based clinical presentation travel history demonstration parasite skin biopsy CL diagnosed patient underwent combination therapy Miltefosine liposomal amphotericin B typical endemic specie detected identified Leishmania major specie that knowledge never reported Bangladesh Proper monitoring reporting imported case given careful consideration clinical epidemiological reasons Molecular test performed diagnosis avoid dilemma identification causative specie prioritized",
        "mesh_terms": [
            "Adult",
            "Antibodies, Protozoan",
            "Bangladesh",
            "Biopsy",
            "Communicable Diseases, Imported",
            "Humans",
            "Immunoassay",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Male",
            "Real-Time Polymerase Chain Reaction",
            "Sequence Analysis, DNA",
            "Skin",
            "Travel"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31699125/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "31649631",
        "title": "Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse.",
        "abstract": "sustain achievement kalaazar elimination program KEP early detection treatment visceral leishmaniasis VL case associated modality treatment failure TF relapse VL RVL Postkalaazar dermal leishmaniasis PKDL cornerstone predictive biomarker VL development related complication could also play crucial role curtailing disease incidence transmission Investigations find biomarker prospective capability are however scarce Using sample known clinical outcome generated within two previous longitudinal cohort studies aimed determine fluctuation serum antirK39 antibody level could provide predictive value Serum sample collected four different time point Baseline 12 18 24 months 16 patient developed VL within monitoring period 15 asymptomatic healthy control counterpart investigated investigate potential prediction VL related complications serum sample 32 PKDL 10 RVL 07 TF 38 cured VL single dose AmBisome trial analyzed second panel patient monitored 5 year serum collected four time point Baseline 1 6 12 month treatment level antirK39 antibody archived sample measured semiquantitative ELISA mean antibody level significantly higher VL patient compared asymptomatic healthy counterpart time point Likewise observed trend toward elevation antibody level PKDL RVL TF relative reducing level observed cured VL Receiver operating characteristic ROC analysis found promising predictive power rK39 antibody level reveal progression asymptomatic iLeishmania donovanii infection stage VL defined 875 sensitive 95 specific Following treatment rk39 antibody notably showed 100 sensitivity 95 specificity predicting TF data indicate relative quantity serum antirK39 antibody promise within either predictive prognostic algorithm VL VLrelated modalities could enable VL control program implement effective measure eliminate disease research is however imperative standardize rK39 antibody ELISA site prior broader use",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31649631/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "31589291",
        "title": "Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani.",
        "abstract": "Visceral leishmaniasis VL Old World caused infection Leishmania donovani Although number new reported case VL Africa relatively stable several years low number currently reported Indian subcontinent suggest positive impact new treatment intervention strategies regions however VL relapse postkalaazar dermal leishmaniasis PKDL maintain infectious reservoir therefore present threat control programs review outline evolving appreciation PKDL impactful disease right discus various diagnostic method applied detection characterization PKDL cases also highlight data indicate potential likely contribution PKDL case ongoing transmission L donovani",
        "mesh_terms": [
            "Disease Reservoirs",
            "Disease Transmission, Infectious",
            "Global Health",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Recurrence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31589291/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "31525195",
        "title": "Effect of insecticide-treated bed nets on visceral leishmaniasis incidence in Bangladesh. A retrospective cohort analysis.",
        "abstract": "Visceral leishmaniasis VL parasitic disease transmitted sand fly specie Phlebotomus argentipes Indian subcontinent Effective vector control highly desirable reduce vector density human vector contact endemic community aim curtail disease transmission evaluated effect long lasting insecticide treated bed net LLIN bed net impregnated slowrelease insecticide tablet KO TAB 123 jointly insecticidetreated net ITN VL incidence highly endemic subdistrict upazila Bangladesh Several distribution LLIN KO TAB 123 selfimpregnation bed net home took place Fulbaria upazila Mymensigh district 2004 2008 three research projects respectively funded CDC Atlanta USA 2004 WHOTDR Geneva Switzerland 2006  2008 included household n  8142 20 village benefited past one intervention 1295 donated LLIN 11918 local bed net impregnated KO TAB 123 exposed cohort recruited nonexposed cohort village contemporaneously similar incidence rate received vector control intervention 7729 HHs nine villages cohorts visited family house house ascertained VL case 3 year period intervention evaluated incidence rate IR VL cohort primary endpoint applying differenceindifferences method study identified 1011 VL case IR 1404710000 per year py intervention 534 477 case intervention control area respectively IR 1441310000 py 53437050 1365910000 py 47734923 intervention control area respectively significant difference p  03901 intervention intervention total 555 case IR 771110000 py identified 178 IR 480410000 py intervention 377 1079510000 py control area intervention area significant lower IR control area follow up rate difference  5991 p00001 IR follow significantly reduced 960910000 py intervention area p00001 286310000 py control area p00001 compared baseline strong significant overall effect ITN intervention δ  6745 p 00001 Sex OR  136 p00001 age OR  099 p00001 also significant effect VL incidence Male higher risk VL female one year increase age decreased likelihood VL 092 Two third VL incidence occurred age range 2 30 year median age VL patient 17 years VL incidence rate significantly lower ITN intervention cohort compared control Bangladesh bias due intense screenandtreat activity intervention intervention area cannot ruled out Nonetheless given feasibility sustainability ITNs considered integrated vector control maintenance phase VL elimination programme",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Animals",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Cohort Studies",
            "Female",
            "Humans",
            "Incidence",
            "Infant",
            "Insect Control",
            "Insect Vectors",
            "Insecticide-Treated Bednets",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Nitriles",
            "Phlebotomus",
            "Pyrethrins",
            "Retrospective Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31525195/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "31415565",
        "title": "Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from Bangladesh.",
        "abstract": "investigated relationship treatment regimen visceral leishmaniasis VL postkalaazar dermal leishmaniasis PKDL visceral leishmaniasis relapse VLR development Study subject included cohort patient cured VL since treatment monotherapy sodium stibogluconate SSG miltefosine MF paromomycin intramuscular injection PMIM liposomal amphotericin B AmBisome AMB single dose SDAMB multidose MDAMB combination therapy AMBPMIM AMBMF PMIMMF Follow period 4 year treatment Cohorts prospective except SSG retrospective MF partially retrospective compared incidence proportion rate 100person4year PKDL VLR treatment regimen using univariate multivariate analysis 974 984 enrolled participant completed study Overall incidence proportion PKDL VLR 123 95 CI 104145 70 95 CI 5688 respectively incidence rate 95 CI PKDL VLR 140 86227 76 41147 accordingly SSG cohort lowest incidence rate PKDL 30 1373 VLR 18 0656 followed MDAMB 82 43157 PKDL 27 0984 VLR Development PKDL VLR related treatment regimen VL SSG MDAMB resulted less incidence PKDL VLR compared treatment regimens MDAMB considered VL first step prevention PKDL VLR since SSG highly toxic recommended VL",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Aged",
            "Aged, 80 and over",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Drug Therapy",
            "Drug Therapy, Combination",
            "Female",
            "Humans",
            "Incidence",
            "Injections, Intramuscular",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Prospective Studies",
            "Recurrence",
            "Retrospective Studies",
            "Treatment Outcome",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31415565/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "31318906",
        "title": "Awareness of residents about kala-azar and its related practices in two endemic areas of Bangladesh.",
        "abstract": "",
        "mesh_terms": [
            "Adult",
            "Animals",
            "Bangladesh",
            "Family Characteristics",
            "Female",
            "Geography",
            "Health Knowledge, Attitudes, Practice",
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Psychodidae"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31318906/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "31108098",
        "title": "A novel multilocus sequence typing scheme identifying genetic diversity amongst Leishmania donovani isolates from a genetically homogeneous population in the Indian subcontinent.",
        "abstract": "Indian subcontinent infection Leishmania donovani cause fatal visceral leishmaniasis Genetic variation L donovani believed occur rapidly environmental change selective drug pressures thereby allowing continued disease occurrence region previous molecular marker commonly use multilocus microsatellite typing multilocus sequence typing monomorphic L donovani originating Indian subcontinent with exceptions hence suitable region multilocus sequence typing scheme consisting new set seven housekeeping gene developed study based recent finding whole genome sequencing data new scheme used assess genetic diversity amongst 22 autochthonous L donovani isolates Bangladesh Nineteen additional isolates L donovani complex including sequence L donovani reference strain BPK282A1 country included comparison using restriction fragment length polymorphism internal transcribed spacer 1 region ITS1RFLP ITS1 sequencing Bangladeshi isolates confirmed L donovani Population genetic analysis 41 isolates using seven new MLST locus clearly separated L donovani Leishmania infantum multilocus sequence typing scheme seven genotype identified amongst Bangladeshi L donovani isolates isolates found phylogenetically different compared India Nepal Iraq Africa novel multilocus sequence typing approach detect intra interspecies variation within L donovani complex importantly molecular marker applied resolve phylogenetically homogeneous L donovani strain Indian subcontinent Four marker found suitable differentiate strain originating Bangladesh marker A2P discriminative one",
        "mesh_terms": [
            "Bangladesh",
            "DNA, Ribosomal Spacer",
            "Genetic Variation",
            "Genotype",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Multilocus Sequence Typing",
            "Phylogeny",
            "Polymorphism, Restriction Fragment Length",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31108098/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "31086147",
        "title": "Miltefosine Induced Reduced Male Fertility Capacity after Treatment of Post Kala-azar Dermal Leishmaniasis, Bangladesh.",
        "abstract": "Post Kalaazar Dermal Leishmaniasis PKDL sequel visceral leishmaniasis Indian subcontinent may appear among patient without previous history visceral leishmaniasis VL aim study understand male reproductive safety profile miltefosine used treatment Post Kalaazar Dermal Leishmaniasis PKDL Bangladesh January 2017 March 2017 exploratory study carried male fertility capacity Bangladesh among male patient 14 year old PKDL treated miltefosine Twenty nine male patient included observe effect miltefosine reproductive health PKDL patient history visceral leishmaniasis VL different time periods Among three 103 patient unable ejaculate semen semen analysis 3 patient 103 found azoospermia sperm count  motility 0 viscosity good pH 7 8 microscopically presence RBC 515HPF WBC 815HPF Another 3 patient 103 found oligospermia sperm count 42 153 millionml motility 20 50 viscosity good pH 6 9 RBC 4 15HPF WBC 4 15HPF study documented important finding evaluating male infertility selection drug regimen treating PKDL patient miltefosine 12 weeks",
        "mesh_terms": [
            "Adolescent",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Fertility",
            "Humans",
            "Infertility, Male",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Male",
            "Phosphorylcholine",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31086147/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30941668",
        "title": "Characterization of Transplasma Membrane Electron Transport Chain in Wild and Drug-Resistant Leishmania donovani Promastigote and Amastigote.",
        "abstract": "Leishmania donovani L donovani one parasite cause leishmaniasis mechanism L donovani fight adverse environment becomes resistant drug well understood yet present study designed evaluate effect different regulator modulation Transplasma Membrane Electron Transport transPMET system susceptible resistant L donovani cells Effects UV different buffers electron transport inhibitor stimulators reduction αlipoic acid ALA 12naphthoquinone4sulphonic acid NQSA ferricyanide determined ALA reduction inhibited susceptible sodium antimony gluconate SAGresistant paromomycin PMMresistant AG83 amastigote cells stimulated susceptible SAGresistant AG83 promastigote cell upon UV exposure result indicate UV irradiation almost oppositely affect ALA reduction amastigotes promastigotes ALA reduction stimulated sensitive inhibited resistant GE1 amastigotes upon UV exposure Susceptible amastigotes promastigotes inhibited resistant amastigotes promastigotes stimulated NQSA reduction UV irradiation Thus susceptible drugresistant amastigotes promastigotes different reduction ALA Susceptible resistant AG83 amastigotes promastigotes inhibited ferricyanide reduction upon UV exposure indicates difference ferricyanide reduction among susceptible well resistant AG83 amastigotes promastigotes reduction extracellular electron excerptors susceptible promastigotes requires availability Nasupsup Clsupsup ion maximal activity susceptible amastigotes mostly dependent availability Nasupsup Clsupsup ions promastigotes amastigotes reduction electron acceptor strongly inhibited carbonyl cyanide ptrifluoromethoxyphenylhydrazone Furthermore antimycin A rotenone capsaicin markedly inhibited reduction electron acceptor promastigotes amastigotes Results study suggest transPMET system functionally different wild resistant strain L donovani",
        "mesh_terms": [
            "Drug Resistance",
            "Electron Transport",
            "Ferricyanides",
            "Leishmania donovani",
            "Life Cycle Stages",
            "Naphthoquinones",
            "Oxidation-Reduction",
            "Paromomycin",
            "Sulfonic Acids",
            "Thioctic Acid",
            "Ultraviolet Rays"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30941668/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30670453",
        "title": "Eliminating visceral leishmaniasis in South Asia: the road ahead.",
        "abstract": "bSuman Rijal colleaguesb highlight lesson regional collaboration eliminate visceral leishmaniasis identify priority postelimination plan",
        "mesh_terms": [
            "Amphotericin B",
            "Animals",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Disease Vectors",
            "Drug Therapy, Combination",
            "Epidemiological Monitoring",
            "Humans",
            "India",
            "International Cooperation",
            "Leishmaniasis, Visceral",
            "Neglected Diseases",
            "Nepal",
            "Paromomycin",
            "Phosphorylcholine",
            "Program Development",
            "Program Evaluation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30670453/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30618453",
        "title": "An investigation about the possible role of cattle and goats as reservoir hosts for <i>Leishmania donovani</i> in Bangladesh.",
        "abstract": "",
        "mesh_terms": [
            "Animals",
            "Animals, Domestic",
            "Antibodies, Protozoan",
            "Bangladesh",
            "Cattle",
            "DNA, Protozoan",
            "Disease Reservoirs",
            "Goats",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Polymerase Chain Reaction"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30618453/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30577877",
        "title": "Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study.",
        "abstract": "Based study India as study outside India amphotericin B deoxycholate considered backup drug treatment visceral leishmaniasis However treatment response adverse effect antileishmanial drug may vary across different population Bangladesh effect amphotericin B deoxycholate treatment visceral leishmaniasis still unknown Therefore need explore cure rate adverse effect amphotericin B deoxycholate justify use visceral leishmaniasis patient Bangladesh report 34 visceral leishmaniasis patient received treatment amphotericin B deoxycholate Surya Kanta Kalaazar Research Centre December 2011 June 2015 dose treatment 1 mgkg body weight 15 day followed 12 month treatment Response amphotericin B deoxycholate treatment excellent 34 patient achieved final cure Hypokalaemia 47 shivering 47 vomiting 35 acidity 15 common adverse events However observe serious adverse events Amphotericin B deoxycholate relapse visceral leishmaniasis found highly effective safe study justified include amphotericin B deoxycholate second line drug visceral leishmaniasis Bangladesh",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Amphotericin B",
            "Anti-Infective Agents",
            "Bangladesh",
            "Child",
            "Cross-Sectional Studies",
            "Deoxycholic Acid",
            "Drug Combinations",
            "Female",
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Recurrence",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30577877/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30577826",
        "title": "Evaluation of rapid extraction and isothermal amplification techniques for the detection of Leishmania donovani DNA from skin lesions of suspected cases at the point of need in Sri Lanka.",
        "abstract": "Leishmaniasis disease caused vectorborne protozoans Sri Lanka cutaneous form disease predominant usually diagnosed using Giemsastained slit skin smear examination histology However sensitivity slit skin smear histology reportedly low Moreover facility highly sensitive polymerase chain reaction PCR available highlyequipped parasitology laboratories Therefore need low cost sensitive specific screening test diagnosis leishmaniasis point need study mobile suitcase laboratory applying novel extraction SpeedXtract isothermal amplification detection recombinase polymerase amplification assay RPA method evaluated diagnosis cutaneous leishmaniasis Sri Lanka First developed assay applied three different sample type punch biopsy slit skin smear fine needle aspirates local hospital result showed 2 mm punch biopsy sample produced best exponential amplification curve early fluorescence signal RPA assay Secondly punch biopsy collected 150 suspected cutaneous leishmaniasis case screened SpeedXtractRPA RNAlaterPCR ATL bufferPCR addition Giemsastained slit skin smears Fiftyseven sample negative detection methods total 93 sample positive assay sensitivity 655 SpeedXtractRPA 634 RNAlaterPCR 924 ATL bufferPCR Giemsastained slit skin smear delivered worst clinical sensitivity 322 SpeedXtractRPA method field condition took 35 min almost 8 h needed finalize extraction detection PCR laboratory SpeedXtractRPA method produced similar sensitivity sample preserved RNAlater subjected PCR amplification less sensitive ATLpreserved sample subjected PCR amplification need standardization sample collection nucleic acid extraction methods",
        "mesh_terms": [
            "Adult",
            "Aged",
            "Chemical Fractionation",
            "DNA, Protozoan",
            "Female",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Male",
            "Middle Aged",
            "Nucleic Acid Amplification Techniques",
            "Point-of-Care Systems",
            "Skin",
            "Sri Lanka",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30577826/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30561583",
        "title": "Reply to Shamim Islam.",
        "abstract": "",
        "mesh_terms": [
            "Amphotericin B",
            "Bangladesh",
            "Humans",
            "Leishmaniasis, Visceral",
            "Prospective Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30561583/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30561535",
        "title": "AmBisome for Kala-azar and Post-kala-azar Dermal Leishmaniasis: An Essential Option but Not a Universal Solution.",
        "abstract": "",
        "mesh_terms": [
            "Amphotericin B",
            "Bangladesh",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Prospective Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30561535/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30541022",
        "title": "Detection of Immunoglobulin G1 Against rK39 Improves Monitoring of Treatment Outcomes in Visceral Leishmaniasis.",
        "abstract": "Visceral leishmaniasis VL caused Leishmania donovani complex fatal neglected tropical disease targeted elimination India Nepal Bangladesh Improved diagnostic test required early case detection monitoring outcome treatments Previous investigation using Leishmania lysate antigen demonstrated immunoglobulin Ig G1 response potential indicator patients clinical status chemotherapy IgG1 IgG enzymelinked immunosorbent assay ELISAs rK39 lysate antigen novel IgG1 rK39 rapid diagnostic test RDTs assessed Indian VL serum sample following clinical groups paired pre postchemotherapy deemed cured relapsed infectious diseases endemic healthy controls paired pre posttreatment sample n  37 pairs ELISAs rK39 IgG1specific conjugate gave far discriminative decrease posttreatment antibody response compared IgG P  0001 Novel IgG1 rK39 RDTs provided strong evidence decreased IgG1 response patient successful treatment P  0001 Furthermore IgG1 rK39 RDTs n  38 ELISAs showed highly significant difference test outcome cured patient relapsed n  23 P  0001 RDTs sensitive corresponding ELISAs present strong evidence use IgG1 monitoring treatment outcome VL first use IgG1based RDT using rK39 antigen discrimination posttreatment cure versus relapse VL RDT may significant role monitoring patient targeted control elimination devastating disease",
        "mesh_terms": [
            "Antibodies, Protozoan",
            "Antigens, Protozoan",
            "Antiprotozoal Agents",
            "Diagnostic Tests, Routine",
            "Enzyme-Linked Immunosorbent Assay",
            "Humans",
            "Immunoglobulin G",
            "Leishmania",
            "Leishmaniasis, Visceral",
            "Recurrence",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30541022/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30487514",
        "title": "Role of Immune Cells and Cytokines for Immune Response in Kala-Azar.",
        "abstract": "Resolution leishmanial infection dependent coordinated interaction component cell mediated immune response central activation targeted Tcell population appropriate cytokine production activation infected cells correlation clinical outcome Leishmania infection cytokine response profile protective immune response Leishmania clearly identified related influence typel response IFNγ production precise role helper TH 2 cytokine nonhealing infection requires exploration Experimental evidence clinical study indicate multifaceted role various factor leading parasite survival multiplication early stage infection generation reactive oxygen nitrogen intermediate play significant role curtailing parasite multiplication later phase hepatic resistance expressed dominant role played nitric oxide synthase NOS2 gene regulation hand production inhibitor NOS2 gene expression interleukin 10 IL10 transforming growth factorβ TGFβ correlate well reduced parasite killing hepatic infection usually selflimiting due production multiple cytokine response including moderate level tumour necrosis factor TNF spleen excess TNF mediates destructive pathology CD8 cell appear play multiple role comprising cytotoxic activity secretion cytokine chemokines better understanding innate acquired immune functioning host could aid rational control better therapeutic intervention disease",
        "mesh_terms": [
            "Cytokines",
            "Humans",
            "Leishmaniasis, Visceral",
            "Spleen"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30487514/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30457088",
        "title": "Intervention Packages for Early Visceral Leishmaniasis Case Detection and Sandfly Control in Bangladesh: A Comparative Analysis.",
        "abstract": "compared efficacy three intervention package active case detection ACD visceral leishmaniasis VLpostkalaazar dermal leishmaniasis PKDL combined sandfly control around index case package 1 kalaazar transmission activity involving indoor residual spraying IRS deltamethrin peridomestic deployment larvicide temephos housetohouse search cases 2 fever camp FC plus durable wall lining DWL deltamethrin 3 FC plus insecticide deltamethrin impregnated bednets ITN around index case Fever camp includes 1day campaign village level screen diagnose VL PKDL leprosy malaria tuberculosis among resident chronic fever skin disease Efficacy measured yield new cases vector density reduction mortality 1 3 6 9 12 month following intervention Fever camp  DWL efficacious intervention package 05 case detected per intervention 79 reduction vector density incidence rate ratio IRR  021 iPi  0010 951 95 confidence interval 934 968 sandfly mortality 12 months kalaazar transmission activity efficacious vector control 74 vector reduction IRR  026 iPi  00001 9 months 84 sandfly mortality 3 months case detection 0 case per intervention Fever camp  ITN efficacious detection VLPKDL case 043 case per intervention efficacy vector control inconsistent recommend index casebased FC ACD combined DWL IRS plus larvicide sandfly control consolidation maintenance phase VL elimination program Indian subcontinent",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Animals",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Cluster Analysis",
            "Disease Vectors",
            "Female",
            "Fever",
            "Humans",
            "Insect Control",
            "Insecticide-Treated Bednets",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Leprosy",
            "Malaria",
            "Male",
            "Phlebotomus",
            "Tuberculosis",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30457088/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30357373",
        "title": "Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.",
        "abstract": "Indian subcontinent visceral leishmaniasis VL incidence track reach elimination goal 2020 nearly endemic districts Although included official targets previous data suggest postkalaazar dermal leishmaniasis PKDL patient act infection reservoir conducted xenodiagnosis 47 PKDL patient 15 VL patient using laboratoryreared Phlebotomus argentipes direct xenodiagnosis fly allowed feed patients skin 15 minutes indirect xenodiagnosis fly fed membrane patients blood Five day later bloodfed fly dissected examined microscopy andor polymerase chain reaction PCR 3mm skin snip biopsy PKDL venous blood VL processed quantitative PCR Twentyseven PKDL patient 574 positive result direct andor indirect xenodiagnosis Direct significantly sensitive indirect xenodiagnosis 553 v 64 P  0001 positive xenodiagnosis median skin parasite load 1 log10 unit higher negative result 288 v 166 P  0001 multivariable model parasite load nodular lesions positive skin microscopy significantly associated positive xenodiagnosis Blood parasite load strongest predictor VL Compared VL nodular PKDL likely macular PKDL less likely result positive xenodiagnosis neither difference reached statistical significance Nodular macular PKDL VL infectious sand flies Active PKDL case detection prompt treatment instituted maintained integral part VL control elimination programs",
        "mesh_terms": [
            "Adult",
            "Animals",
            "Disease Reservoirs",
            "Disease Transmission, Infectious",
            "Female",
            "Humans",
            "Insect Vectors",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Psychodidae"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30357373/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30320150",
        "title": "Evaluation of Real-time PCR for Diagnosis of Post-Kala-azar Dermal Leishmaniasis in Endemic Foci of Bangladesh.",
        "abstract": "Postkalaazar dermal leishmaniasis PKDL sequel visceral leishmaniasis VL found VLendemic country including Bangladesh enigmatic cases success National Kalaazar Elimination Program threat date diagnostic method PKDL case endemic region limited clinical examination rK39 test microscopy suitable accurate alternative method needed study investigated application realtime polymerase chain reaction PCR potential method diagnosis PKDL comparison microscopy Ninetyone suspected macular PKDL case Mymensingh district Bangladesh enrolled study diagnosis clinical examination rK39 strip test responded completion treatment miltefosine enrollment skin biopsy done patient microscopy realtime PCR performed detection quantification iLeishmania donovani body LDB LD DNA respectively Realtime PCR detected 83 case among suspected PKDL patients encouraging sensitivity 912 834961 whereas microscopy showed 506 399612 sensitivity Among suspected PKDL cases 42 case positive microscopy qPCR whereas 41 case detected positive qPCR only study provides evidence realtime PCR promising tool diagnosis PKDL endemic regions addition diagnosis quantitative ability method could exploited aftertreatment prognosis cure assessment PKDL cases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30320150/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30296295",
        "title": "The role of case proximity in transmission of visceral leishmaniasis in a highly endemic village in Bangladesh.",
        "abstract": "Visceral leishmaniasis VL characterised high degree spatial clustering scales feature remains even successful control measures VL targeted elimination public health problem Indian subcontinent 2020 incidence falling rapidly since 2011 Current control based early diagnosis treatment clinical cases blanket indoor residual spraying insecticide IRS endemic village kill sandfly vectors Spatially targeting active case detection andor IRS higher risk area would greatly reduce cost control effectiveness control strategy unknown effectiveness depends two key unknowns quickly transmission risk decrease distance VL case much asymptomatically infected individual contribute transmission estimate key parameters spatiotemporal transmission model VL developed fitted geolocated epidemiological data 2494 individual highly endemic village Mymensingh Bangladesh Bayesian inference framework could account unknown infection time VL cases missing symptom onset recovery times developed perform parameter estimation parameter estimate obtained suggest that highly endemic setting VL risk decrease relatively quickly distance casehalving within 90mand VL case contribute significantly transmission asymptomatic individuals result suggest spatiallytargeted intervention may effective limiting transmission However extent spatial transmission pattern asymptomatic contribution vary VL endemicity time uncertain event intervention would need performed promptly large radius ≥300m around new case reduce transmission risk",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Aged",
            "Aged, 80 and over",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Disease Transmission, Infectious",
            "Endemic Diseases",
            "Epidemiologic Studies",
            "Female",
            "Geography",
            "Humans",
            "Infant",
            "Infant, Newborn",
            "Leishmaniasis, Visceral",
            "Longitudinal Studies",
            "Male",
            "Middle Aged",
            "Models, Statistical",
            "Rural Population",
            "Spatio-Temporal Analysis",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30296295/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30273402",
        "title": "Indoor residual spraying for kala-azar vector control in Bangladesh: A continuing challenge.",
        "abstract": "Visceral leishmaniasis VL Indian subcontinent fatal disease left untreated 1994 2013 Ministry Health Bangladesh reported 109266 case VL 329 VL related death 37 endemic districts Indoor residual spraying IRS using dichlorodiphenyltrichloroethane DDT used national programme 1960s control malaria Despite finding research trial demonstrating synthetic pyrethroid deltamethrin 5 WP effective reducing vector densities national VL vector control operation took place Bangladesh 1999 early 2012 2012 IRS using deltamethrin 5 WP reintroduced national programme consisted premonsoon spraying eight highly endemic subdistricts upazilas present study aim evaluate effectiveness IRS VL vectors well process performance spraying activity national programme staff Five highly endemic upazilas Mymensingh district purposively selected Fulbaria Trishal Mukthagacha Gaforgaon Bhaluka conduct present study using WHOTDR monitoring evaluation tool kit IRS operations conducted 136 squadsteams 544 spraymen observed using check list questionnaire included WHOTDR monitoring evaluation tool kit household HH acceptability survey IRS conducted study area using structured questionnaire 600 HHs measure efficacy IRS preIRS two week prior postIRS at one five month after vector density measured using CDC light trap two consecutive nights Bioassays using conemethod carried 80 HHs 40 sprayed 40 unsprayed measure effectiveness insecticide sprayed surfaces 544 spraymen interviewed preIRS 60 3 37 received training one two three day respectively spraying activities 64 spraying squad supervisor 4 upazilas one upazila Mukthagacha achieved 100 supervision squads Overall 728 spraying squad study upazilas informed HHs member prepare house prior spraying required personal protective equipment provided national programme observation spraying technique used sprayer substandard compared standard procedure mentioned ME toolkit HH interviews 948 600 respondent said living room cattle shed sprayed Regarding effectiveness measurement ie reduction vector densities total 4132 sand fly trapped three intervals 3310 801 P argentipes 465 1540 male 535 1770 females one month postIRS P argentipes density reduced 225 5 month postIRS reduction 64 male female bioassay test showed mean corrected mortality P argentipes sand fly one month postIRS 873 dropped 745 4 month postIRS three upazilas threshold level 80 national programme conduct monitoring evaluation activity ensure high quality IRS operation precondition achieving fast sustained reduction vector densities continue important maintenance phase VL elimination Indian subcontinent research needed determine suitable vector control options case number low",
        "mesh_terms": [
            "Aerosols",
            "Animals",
            "Bangladesh",
            "Biological Assay",
            "Family Characteristics",
            "Health Services Research",
            "Humans",
            "Insect Control",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Nitriles",
            "Patient Acceptance of Health Care",
            "Population Density",
            "Psychodidae",
            "Pyrethrins",
            "Surveys and Questionnaires",
            "Survival Analysis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30273402/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30222747",
        "title": "Corneal complications following Post Kala-azar Dermal Leishmaniasis treatment.",
        "abstract": "Post Kalaazar Dermal Leishmaniasis PKDL sequel Visceral Leishmaniasis VL patient act reservoir causative parasite ie Leishmania donovani thus diagnosed treated utmost urgency prevent transmission disease study tried report first instance corneal complication supposedly associated Miltefosine MF PKDL patient probable pathophysiology events recently rejuvenated National Kalaazar Elimination Program Bangladesh put great emphasis monitoring leishmaniasis patient investigate possible adverse drug reaction ADR total 194 patient received Miltefosine treatment Post Kalaazar Dermal Leishmaniasis far five patient found developed unilateral ophthalmic complication period May 2016 October 2017 treated MF PKDL Unfortunately one go complete evisceration affected eyeball Despite fact MF oral formulation choice treat PKDL occurrence unexpected ADRs MF administration urge exploration pathogenesis incident determine measure avert occurrence happening future",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Humans",
            "Keratitis",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Phosphorylcholine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30222747/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30141437",
        "title": "Clinical Characteristics and Haematological Parameters Associated With Visceral Leishmaniasis in Bangladeshi Individuals.",
        "abstract": "Visceral leishmaniasis VL also known kalaazar KA severe form leishmaniasis fatal absence treatment KA highly endemic Mymensingh region Bangladesh Although estimating true incidence VL may difficult objective study evaluate clinicohaematological parameter different group leishmaniasis cases crosssectional descriptive type study conducted research centre Mymensingh Bangladesh February 2016 January 2017 total 90 case rk39 strip test positive five division Bangladesh admitted Research Centre included clinical haematological parameters case categorized five different group depending clinical case definition Real Time PCR RTPCR performed using buffy coat preparation age study subject ranged 3 80 years Mymensingh highest affected division 60 primary kala azar PKA case half study subjects Fever common feature 100 PKA relapse kala azar RKA treatment failure kala azar TFKA followed splenomegaly 702 PKA loss appetite 629 RKA skin pigmentation observed 100 PKDL cases Anaemia present 627 leucopenia 576 thrombocytopenia 617 PKA cases Pancytopenia observed total 33 case groups significant change serum bilirubin SGPT serum creatinine level RTPCR performed case found positive 30 638 PKA 16 593 RKA 2 100 TFKA 2 50 RKA associated PKDL cases Overall VL case positive 625 5080 PKDL case detected buffycoat RTPCR endemic areas magnitude problem limited resource developing country like ours clinical characteristic hematological parameter may also play important role diagnosis clinical cases",
        "mesh_terms": [
            "Bangladesh",
            "Cross-Sectional Studies",
            "Fever",
            "Humans",
            "Leishmaniasis, Visceral"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30141437/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "30099967",
        "title": "Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.",
        "abstract": "Adverse effect antileishmanial drug affect patients quality life adherence therapy visceral leishmaniasis VL postkalaazar dermal leishmaniasis PKDL Bangladesh 26 treatment center manage leishmaniasis case coming 100 endemic upazilas subdistricts 26 district these include VL PKDL treatment failure relapse VL cutaneous leishmaniasis cases study aimed investigate feasibility using focused pharmacovigilance VL VLPV Bangladeshs National Kalaazar Elimination Programme early detection prevention expected unexpected adverse drug reaction ADRs activity going since December 2014 Activity area includes secondary public hospital Upazila health complex UHC hundred sub district Surya Kanta Kalaazar Research Center SKKRC Mymensingh District specialized center management complicated VL PKDL cases Communicable Disease Control CDC Directorate General Health Services DGHS assigned twenty five hundred UHCs SKKRC total 26 treatment center depending suitable geographical location implemented better management VL case Liposomal Amphotericin B AmBisome® ensure patient convenience proper utilization expensive donated drug VLPV expert committee UHC VLPV team established operational manual pharmacovigilance report form developed training refresher training health personnel took place UHCs central level collected information patient data including demographics treatment history response adverse event analyzed report includes information period December 2014 December 2016 December 2014 December 2016 1327 leishmaniasis patient treated 1066 80 available VLPV these 57 33 9 1 new VL PKDL VL relapse cases respectively Liposomal amphotericin B mostly used 82 case management followed miltefosine 20 paromomycin 3 1066 patients 26 experienced ADRs frequent ADR fever 17 1761066 followed vomiting 5 511066 Thirteen serious adverse event SAEs eight death five unexpected SAEs observed expert committee assessed three death unexpected SAEs possibly related treatment five unexpected SAEs four miltefosineinduced ophthalmic complication AmBisome®induced avascular necrosis nasal alae Directorate General Drug Administration entered ADRs World Health Organization Uppsala Monitoring Centre WHOUMC VigiFlow database study found VLPV NKEP feasible continued routine activity public health system Bangladesh ensure patient safety antileishmanial drugs",
        "mesh_terms": [
            "Acute Kidney Injury",
            "Adolescent",
            "Adult",
            "Aged",
            "Amphotericin B",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Female",
            "Humans",
            "Leishmania donovani",
            "Leishmania tropica",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Myocardial Infarction",
            "Paromomycin",
            "Patient Safety",
            "Pharmacovigilance",
            "Phosphorylcholine",
            "Quality of Life",
            "Recurrence",
            "Survival Analysis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30099967/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "29866195",
        "title": "Susceptibility of field-collected Phlebotomus argentipes (Diptera: Psychodidae) sand flies from Bangladesh and Nepal to different insecticides.",
        "abstract": "sand fly Phlebotomus argentipes vector visceral leishmaniasis VL Indian subcontinent Bangladesh since 2012 indoor residual spraying IRS applied VL endemic area using deltamethrin Nepal IRS initiated 1992 VL vector control using lambdacyhalothrin Irrational use insecticide may lead vector resistance little information subject available countries objective study generate information susceptibility vector sand fly P argentipes insecticide support VL elimination initiative Indian subcontinent Susceptibility test performed using test kit following standard procedure regarding alpha cypermethrin 005 deltamethrin 005 lambdacyhalothrin 005 permethrin 075 malathion 5 bendiocarb 01 six upazilas subdistricts Bangladesh Nepal test performed two insecticides alpha cypermethrin 005 deltamethrin 005 Adult P argentipes sand fly collected Bangladesh six VL endemic upazilas subdistricts Nepal three endemic district using manual aspirators result show VL vector highly susceptible insecticide 60 minute exposure countries Bangladesh corrected mortality 100 15 minute well 30 minute exposure study site Nepal however showed diverse results mortality rate less 90 15 minute exposure alpha cypermethrin deltamethrin two district 95 30 minute exposure result suggest insecticide tested still used national programme Bangladesh Nepal However insecticide rotation performed mitigate possible development insecticide resistance Periodic susceptibility test performed country get timely alert regarding insecticide resistance",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Female",
            "Humans",
            "Insect Control",
            "Insect Vectors",
            "Insecticides",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Male",
            "Nepal",
            "Nitriles",
            "Phlebotomus",
            "Pyrethrins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/29866195/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "29860031",
        "title": "Potential of cell-free DNA as a screening marker for parasite infections in dog.",
        "abstract": "Parasitic infection common stray dog accurate knowledge parasite community dog would provide insight epidemiology parasitic diseases study used Illumina sequencing technology evaluate cellfree DNA cfDNA marker screening parasitic infection dogs Plasma sample 14 stray dog captured Bangladesh used experiments average 23 million read obtained sample BLASTn analysis identified 150 read high similarity parasite 19 different genera particular detected sequence Babesia spp five dogs consistent this previous study using conventional PCR showed four dog positive B gibsoni Several read similarity Leishmania filarial nematode also identified finding indicate cfDNA blood potential screening marker identifying parasite diversity dogs",
        "mesh_terms": [
            "Animals",
            "Babesia",
            "Babesiosis",
            "Cell-Free Nucleic Acids",
            "DNA, Protozoan",
            "Dog Diseases",
            "Dogs",
            "Leishmania",
            "Leishmaniasis",
            "Molecular Diagnostic Techniques"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/29860031/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "29775824",
        "title": "Is urine a reliable clinical sample for the diagnosis of human visceral leishmaniasis? A systematic review and meta-analysis.",
        "abstract": "Visualization amastigotes lymph nodes bone marrow tissue sample remains gold standard method diagnosis visceral leishmaniasis VL humans gold standard diagnostic method us technically challenging microscopy procedure often accessible many place world VL endemic Here report current systematic review metaanalysis evaluate whether urine reliable clinical sample diagnosis human VL Data extracted ten available database period 2002 2017 Overall 29 article fulfilled inclusion criterion used data extraction systematic review study 724 using urine specimen reported five countries India 6 207 Iran 5 172 Bangladesh 4 138 Japan 3 103 Spain 3 103 respectively common diagnostic test performed urine Katex 621 ELISA 241 rK39 172 assays metaanalysis sensitivity specificity three commonly used diagnostic assay rK39 97 CI 9199 9876100 ELISA 91 8295 99 CI 94100 Katex 83 7390 98 98100 suggesting rK39 assay provided highest sensitivity ELISA assay provided highest specificity diagnosis VL urine samples finding suggest urine valuable clinical sample diagnosis human VL particularly area gold standard test VL available",
        "mesh_terms": [
            "Antigens, Protozoan",
            "Enzyme-Linked Immunosorbent Assay",
            "Humans",
            "Latex Fixation Tests",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Molecular Diagnostic Techniques",
            "Polymerase Chain Reaction",
            "Protozoan Proteins",
            "Reagent Kits, Diagnostic",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/29775824/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "29642962",
        "title": "Leishmaniasis: current challenges and prospects for elimination with special focus on the South Asian region.",
        "abstract": "Leishmania donovani virulent specie Leishmania found South Asian region harbour majority visceral leishmaniasis VL case world traditionally accepted relationship causative specie Leishmania resultant disease phenotype challenged recent year underscored importance revisiting previously established taxonomy revision classification weak voice afflicted decade neglect scientist policy maker led miserably inadequate slow advancement product development field diagnostics chemotherapeutics vector control continue hinder effective management control infection Limitations notwithstanding regional drive elimination VL initiated decade ago focused India Nepal Bangladesh three main afflicted country Indian subcontinent therefore commendable subsequent status review restructuring strategy possibly even so However renewed effort would need combined plan combat new challenge SouthAsian region includes emergence atypical parasite variants order realistically achieve set goal regional elimination VL",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Disease Eradication",
            "Humans",
            "India",
            "Leishmania donovani",
            "Leishmaniasis",
            "Leishmaniasis, Visceral",
            "Neglected Diseases",
            "Nepal",
            "Psychodidae"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/29642962/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "29554244",
        "title": "Safety and Effectiveness of Short-Course AmBisome in the Treatment of Post-Kala-Azar Dermal Leishmaniasis: A Prospective Cohort Study in Bangladesh.",
        "abstract": "safe effective shortcourse treatment regimen postkalaazar dermal leishmaniasis PKDL considered essential achieving sustaining elimination visceral leishmaniasis VL Indian subcontinent 1 2 Here singledose liposomal amphotericin B AmBisome adopted firstline regimen VL however effectiveness safety AmBisome PKDL formally evaluated safety effectiveness AmBisome 15 mgkg given 15 day 5 biweekly infusion 3 mgkg outpatient basis evaluated April November 2014 patient clinically diagnosed PKDL aged ≥12 year residing highly VLendemic area Bangladesh prospective cohort observational study objective assess final cure 12 month treatment Clinical response monitored 1 3 6 12 months safety treatment 1 month treatment 280 patient meeting inclusion criteria 273 assessed 12 months complete major improvement lesion seen 245 patient 897 213 780 considered completely cured Lesions improve 28 103 new lesion appeared 13 48 patient completed treatment without severe serious adverse events shortcourse 15mgkg AmBisome regimen proved safe effective treatment clinically diagnosed PKDL Bangladesh considered treatment option routine programmatic use VL elimination effort Indian subcontinent",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Amphotericin B",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Female",
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Prospective Studies",
            "Recurrence",
            "Treatment Outcome",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/29554244/",
        "source_type": "Bangladesh-specific"
    }
]